[go: up one dir, main page]

Next Issue
Volume 9, March
Previous Issue
Volume 9, January
 
 
nutrients-logo

Journal Browser

Journal Browser

Nutrients, Volume 9, Issue 2 (February 2017) – 94 articles

Cover Story (view full-size image): Metabolic vulnerability is associated with age-related diseases and concomitant co-morbidities, which include obesity, diabetes, atherosclerosis and cancer. Phenotypic heterogeneity and individual response to metabolic stressors are closely related food intake. Understanding the complexity of the relationship between dietary provision and metabolic consequences in the long term might provide clinical strategies to improve healthspan. New aspects of metformin activity provide a link to many of the overlapping factors, especially the way in which organismal bioenergetics remodel one-carbon metabolism. Metformin not only inhibits mitochondrial complex 1, modulating the metabolic response to nutrient intake, but also alters one-carbon metabolic pathways. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
1773 KiB  
Review
The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism
by Katsumi Iizuka
Nutrients 2017, 9(2), 181; https://doi.org/10.3390/nu9020181 - 22 Feb 2017
Cited by 56 | Viewed by 15686
Abstract
Many articles have discussed the relationship between fructose consumption and the incidence of obesity and related diseases. Fructose is absorbed in the intestine and metabolized in the liver to glucose, lactate, glycogen, and, to a lesser extent, lipids. Unabsorbed fructose causes bacterial fermentation, [...] Read more.
Many articles have discussed the relationship between fructose consumption and the incidence of obesity and related diseases. Fructose is absorbed in the intestine and metabolized in the liver to glucose, lactate, glycogen, and, to a lesser extent, lipids. Unabsorbed fructose causes bacterial fermentation, resulting in irritable bowl syndrome. Therefore, understanding the mechanisms underlying intestinal and hepatic fructose metabolism is important for the treatment of metabolic syndrome and fructose malabsorption. Carbohydrate response element binding protein (ChREBP) is a glucose-activated transcription factor that controls approximately 50% of de novo lipogenesis in the liver. ChREBP target genes are involved in glycolysis (Glut2, liver pyruvate kinase), fructolysis (Glut5, ketohexokinase), and lipogenesis (acetyl CoA carboxylase, fatty acid synthase). ChREBP gene deletion protects against high sucrose diet-induced and leptin-deficient obesity, because Chrebp−/− mice cannot consume fructose or sucrose. Moreover, ChREBP contributes to some of the physiological effects of fructose on sweet taste preference and glucose production through regulation of ChREBP target genes, such as fibroblast growth factor-21 and glucose-6-phosphatase catalytic subunits. Thus, ChREBP might play roles in fructose metabolism. Restriction of excess fructose intake will be beneficial for preventing not only metabolic syndrome but also irritable bowl syndrome. Full article
Show Figures

Figure 1

Figure 1
<p>ChREBP regulates fructolytic gene expression. Fructose is transported by GLUT5 and metabolized by ketohexokinase, aldolase B, and triokinase. Dihydroxyacetone phosphate and glyceraldehyde-3-phosphate enter into the glycolytic or gluconeogenic pathway. * Genes are regulated by ChREBP [<a href="#B14-nutrients-09-00181" class="html-bibr">14</a>,<a href="#B20-nutrients-09-00181" class="html-bibr">20</a>,<a href="#B23-nutrients-09-00181" class="html-bibr">23</a>,<a href="#B24-nutrients-09-00181" class="html-bibr">24</a>,<a href="#B25-nutrients-09-00181" class="html-bibr">25</a>]. <span class="html-italic">Khk</span>, ketohexokinase; <span class="html-italic">G6pc</span>, glucose-6-phosphatase catalytic subunit; <span class="html-italic">Aldb</span>, aldolase B; <span class="html-italic">Pklr</span>, pyruvate kinase, liver and reticulocyte type; <span class="html-italic">Acc</span>, acetyl coA carboxylase; <span class="html-italic">Fasn</span>, fatty acid synthase; <span class="html-italic">Tkfc</span>, triokinase; ChREBP, carbohydrate response element binding protein; GLUT2, glucose transporter 2; GLUT5, glucose transporter 5; DHAP, Dihydroxyacetone phosphate; ATP, adenosine triphosphate; ADP, adenosine diphosphate; AMP, adenosine monophosphate.</p>
Full article ">Figure 2
<p>Metabolic fate of fructose. Fructose is slowly absorbed in the intestine. If excess fructose is consumed, unabsorbed fructose causes bacterial fermentation and, thereby, irritable bowel syndrome. Absorbed fructose is converted into glucose (50%), glycogen (~17%), lactate (25%), and triacylglycerol (TAG) (1%) [<a href="#B11-nutrients-09-00181" class="html-bibr">11</a>].</p>
Full article ">Figure 3
<p>ChREBP transactivities are regulated by several factors. ChREBP is activated by glucose derived metabolites and suppressed by AMP, ketone bodies and cyclic cAMP [<a href="#B43-nutrients-09-00181" class="html-bibr">43</a>,<a href="#B44-nutrients-09-00181" class="html-bibr">44</a>,<a href="#B45-nutrients-09-00181" class="html-bibr">45</a>,<a href="#B46-nutrients-09-00181" class="html-bibr">46</a>,<a href="#B47-nutrients-09-00181" class="html-bibr">47</a>,<a href="#B48-nutrients-09-00181" class="html-bibr">48</a>,<a href="#B49-nutrients-09-00181" class="html-bibr">49</a>,<a href="#B50-nutrients-09-00181" class="html-bibr">50</a>,<a href="#B51-nutrients-09-00181" class="html-bibr">51</a>,<a href="#B52-nutrients-09-00181" class="html-bibr">52</a>]. AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase; cAMP, cyclic AMP.</p>
Full article ">Figure 4
<p>ChREBP has an important role in regulating glucose and lipid metabolism. Glucose and fructose regulate many genes expression through ChREBP activation [<a href="#B14-nutrients-09-00181" class="html-bibr">14</a>,<a href="#B20-nutrients-09-00181" class="html-bibr">20</a>,<a href="#B23-nutrients-09-00181" class="html-bibr">23</a>,<a href="#B24-nutrients-09-00181" class="html-bibr">24</a>,<a href="#B25-nutrients-09-00181" class="html-bibr">25</a>]. <span class="html-italic">Glut2</span>, glucose transporter 2; <span class="html-italic">Glut4</span>, glucose transporter 4; <span class="html-italic">Pklr</span>, pyruvate kinase, liver and red blood cell; <span class="html-italic">Glut5</span>, glucose transporter 5; <span class="html-italic">Khk</span>, ketohexokinase; <span class="html-italic">Fasn</span>, fatty acid synthase; <span class="html-italic">Acc1</span>, acetyl coA carboxylase 1; <span class="html-italic">Scd1</span>, stearoyl CoA desaturase; <span class="html-italic">G6pc</span>, glucose-6-phosphatase catalytic subunit; <span class="html-italic">Fbp1</span>, fructose-1,6-bisphosphatase 1; <span class="html-italic">G6pdh</span>, hexose-6-phosphate dehydrogenase; <span class="html-italic">Tkt</span>, transketolase; <span class="html-italic">Mttp</span>, microsomal triglyceride transfer protein; <span class="html-italic">Klf10</span>, kruppel-like factor 10; <span class="html-italic">Klf15</span>, kruppel-like factor 15; <span class="html-italic">BHLHE40</span>, basic helix-loop-helix family, member E40; <span class="html-italic">Bhlhb2</span>, Basic helix-loop-helix domain-containing protein, class B; <span class="html-italic">Hnf1a</span>, hepatocyte nuclear factor 1a; <span class="html-italic">Hif1</span>, hypoxia inducible factor 1; <span class="html-italic">Fgf21</span>, fibroblast growth factor 21; <span class="html-italic">Angptl8</span>, angiopoietin like 8; <span class="html-italic">Gcgr</span>, glucagon receptor; <span class="html-italic">Adipor2</span>, adiponectin receptor 2.</p>
Full article ">Figure 5
<p>Fructose induces G6pc and Fgf21 gene expression thorugh ChREBP activation. ChREBP-α regulates ChREBP target genes expression. In turn, products of ChREBP target genes (ChREBP-β, G6pc, Gcgr, and Fgf-21) might suppress ChREBP transactivity [<a href="#B20-nutrients-09-00181" class="html-bibr">20</a>,<a href="#B21-nutrients-09-00181" class="html-bibr">21</a>,<a href="#B22-nutrients-09-00181" class="html-bibr">22</a>,<a href="#B67-nutrients-09-00181" class="html-bibr">67</a>,<a href="#B73-nutrients-09-00181" class="html-bibr">73</a>]. FGF-21 suppress ChREBP transactivity by decreasing sweets intake [<a href="#B70-nutrients-09-00181" class="html-bibr">70</a>,<a href="#B71-nutrients-09-00181" class="html-bibr">71</a>]. GCGR might suppress ChREBP activity by enhancing glucagon effects and thereby protein kinase A activity. G6PC might suppress ChREBP activity by decreasing intracellular G6P levels. G6PC, glucose-6-phosphatase catalytic subunit; GCGR, glucagon receptor; FGF21, fibroblast growth factor-21; G6P, glucose -6-phosphate; ChREBP, carbohydrate response element binding protein.</p>
Full article ">
651 KiB  
Article
The Effects of Iodine Fortified Milk on the Iodine Status of Lactating Mothers and Infants in an Area with a Successful Salt Iodization Program: A Randomized Controlled Trial
by Pantea Nazeri, Parvin Mirmiran, Zhale Tahmasebinejad, Mehdi Hedayati, Hossein Delshad and Fereidoun Azizi
Nutrients 2017, 9(2), 180; https://doi.org/10.3390/nu9020180 - 22 Feb 2017
Cited by 13 | Viewed by 8121
Abstract
Iodine deficiency during the first two years of life may cause irreversible brain damage and mental retardation. The aim of the present study was to investigate, for the first time, the effect of iodine fortified milk on the iodine status of lactating mothers [...] Read more.
Iodine deficiency during the first two years of life may cause irreversible brain damage and mental retardation. The aim of the present study was to investigate, for the first time, the effect of iodine fortified milk on the iodine status of lactating mothers and their infants. In this multicenter randomized controlled trial, 84 lactating mother-infant pairs from health care centers were randomly selected. After meeting the inclusion criteria, lactating mothers were randomly assigned to two groups: the iodine fortified milk group and the control group (n = 42 each). Maternal and infant urine and breast milk samples were collected at 3–5 (baseline), 7, 10, 14 days, and 1 month postpartum, for a measurement of the iodine concentration. A total of 84 lactating mothers, with a mean age of 28.2 ± 4.5 years, and 84 infants, with a mean age of 4.2 ± 0.7 days, were included in the study. Compared to mothers of the control group, mothers receiving iodine fortified milk had higher urinary (p < 0.001) and breast milk (p < 0.001) iodine concentrations. Urinary iodine levels in infants revealed no significant differences between the two groups. The findings of this study indicate that supplementation with daily iodine fortified milk provides iodine nutrition adequacy among lactating mothers. However, it had no effect on the iodine status of infants, who were previously iodine sufficient. Full article
Show Figures

Figure 1

Figure 1
<p>The study profile at a glance.</p>
Full article ">Figure 2
<p>The effect of iodine fortified milk on maternal and infant urinary and breast milk iodine concentrations. (<b>A</b>) Urinary iodine concentration (μg/L) of mothers; (<b>B</b>) urinary iodine concentration (μg/L) of infants and (<b>C</b>) breast milk iodine concentration (μg/L). Data are presented as the median and error bars are the differences between the median, and the 1st and 3rd quartiles.</p>
Full article ">
512 KiB  
Article
Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial
by Vincenzo Arcoraci, Marco Atteritano, Francesco Squadrito, Rosario D’Anna, Herbert Marini, Domenico Santoro, Letteria Minutoli, Sonia Messina, Domenica Altavilla and Alessandra Bitto
Nutrients 2017, 9(2), 179; https://doi.org/10.3390/nu9020179 - 22 Feb 2017
Cited by 48 | Viewed by 8311
Abstract
Genistein has a preventive role against bone mass loss during menopause. However, experimental data in animal models of osteoporosis suggest an anti-osteoporotic potential for this isoflavone. We performed a post-hoc analysis of a previously published trial investigating the effects of genistein in postmenopausal [...] Read more.
Genistein has a preventive role against bone mass loss during menopause. However, experimental data in animal models of osteoporosis suggest an anti-osteoporotic potential for this isoflavone. We performed a post-hoc analysis of a previously published trial investigating the effects of genistein in postmenopausal women with low bone mineral density. The parent study was a randomized, double-blind, placebo-controlled trial involving postmenopausal women with a femoral neck (FN) density <0.795 g/cm2. A cohort of the enrolled women was, in fact, identified at the baseline as osteoporotic (n = 121) on the basis of their T-score and analyzed thereafter for the 24 months’ treatment with either 1000 mg of calcium and 800 IU vitamin D3 (placebo; n = 59); or calcium, vitamin D3, and Genistein aglycone (54 mg/day; genistein; n = 62). According to the femoral neck T-scores, 31.3% of the genistein and 30.9% of the placebo recipients were osteoporotic at baseline. In the placebo and genistein groups, the 10-year hip fracture probability risk assessed by Fracture Risk Assessment tool (FRAX) was 4.1 ± 1.9 (SD) and 4.2 ± 2.1 (SD), respectively. Mean bone mineral density (BMD) at the femoral neck increased from 0.62 g/cm2 at baseline to 0.68 g/cm2 at 1 year and 0.70 g/cm2 at 2 years in genistein recipients, and decreased from 0.61 g/cm2 at baseline to 0.60 g/cm2 at 1 year and 0.57 g/cm2 at 2 years in placebo recipients. At the end of the study only 18 postmenopausal women had osteoporosis in the genistein group with a prevalence of 12%, whereas in the placebo group the number of postmenopausal women with osteoporosis was unchanged, after 24 months. This post-hoc analysis is a proof-of concept study suggesting that genistein may be useful not only in postmenopausal osteopenia but also in osteoporosis. However, this proof-of concept study needs to be confirmed by a large, well designed, and appropriately focused randomized clinical trial in a population at high risk of fractures. Full article
(This article belongs to the Special Issue Dietary Bioactives and Bone Health)
Show Figures

Figure 1

Figure 1
<p>Femoral Neck Bone mineral density changes in absolute values over time in placebo and genistein group. (<b>left</b>) Femoral neck Bone Mineral Density changes in osteoporotic postmenopausal women groups; (<b>right</b>) Femoral neck Bone Mineral Density changes in osteopenic postmenopausal women groups. 2-way ANOVA: Over time, genistein vs. placebo: * Treatment <span class="html-italic">p</span> = 0.0046; # Treatment <span class="html-italic">p</span> = 0.0130; * Time <span class="html-italic">p</span> = 0.0068; # Time <span class="html-italic">p</span> = 0.4929; * Interaction <span class="html-italic">p</span> = 0.0073; # Interaction <span class="html-italic">p</span> = 0.0241.</p>
Full article ">
1237 KiB  
Article
The Effect of Simulated Flash-Heat Pasteurization on Immune Components of Human Milk
by Brodie Daniels, Stefan Schmidt, Tracy King, Kiersten Israel-Ballard, Kimberly Amundson Mansen and Anna Coutsoudis
Nutrients 2017, 9(2), 178; https://doi.org/10.3390/nu9020178 - 22 Feb 2017
Cited by 26 | Viewed by 7905
Abstract
A pasteurization temperature monitoring system has been designed using FoneAstra, a cellphone-based networked sensing system, to monitor simulated flash-heat (FH) pasteurization. This study compared the effect of the FoneAstra FH (F-FH) method with the Sterifeed Holder method currently used by human milk banks [...] Read more.
A pasteurization temperature monitoring system has been designed using FoneAstra, a cellphone-based networked sensing system, to monitor simulated flash-heat (FH) pasteurization. This study compared the effect of the FoneAstra FH (F-FH) method with the Sterifeed Holder method currently used by human milk banks on human milk immune components (immunoglobulin A (IgA), lactoferrin activity, lysozyme activity, interleukin (IL)-8 and IL-10). Donor milk samples (N = 50) were obtained from a human milk bank, and pasteurized. Concentrations of IgA, IL-8, IL-10, lysozyme activity and lactoferrin activity were compared to their controls using the Student’s t-test. Both methods demonstrated no destruction of interleukins. While the Holder method retained all lysozyme activity, the F-FH method only retained 78.4% activity (p < 0.0001), and both methods showed a decrease in lactoferrin activity (71.1% Holder vs. 38.6% F-FH; p < 0.0001) and a decrease in the retention of total IgA (78.9% Holder vs. 25.2% F-FH; p < 0.0001). Despite increased destruction of immune components compared to Holder pasteurization, the benefits of F-FH in terms of its low cost, feasibility, safety and retention of immune components make it a valuable resource in low-income countries for pasteurizing human milk, potentially saving infants’ lives. Full article
Show Figures

Figure 1

Figure 1
<p>Flow diagram illustrating sample handling and processing. F-FH: FoneAstra Flash Heat.</p>
Full article ">Figure 2
<p>Effect of F-FH and Holder pasteurization on the retention of immune components expressed as percentage retention (percentage of control). (<b>A</b>) Lactoferrin; (<b>B</b>) Lysozyme; (<b>C</b>) IL-10; (<b>D</b>) IL-8 and (<b>E</b>) IgA. Bars represent means ± SD. * &lt;0.0001. F-FH: FoneAstra Flash Heated; IL: Interleukin; SD: standard deviation; IgA: Immunoglobulin A.</p>
Full article ">Figure 2 Cont.
<p>Effect of F-FH and Holder pasteurization on the retention of immune components expressed as percentage retention (percentage of control). (<b>A</b>) Lactoferrin; (<b>B</b>) Lysozyme; (<b>C</b>) IL-10; (<b>D</b>) IL-8 and (<b>E</b>) IgA. Bars represent means ± SD. * &lt;0.0001. F-FH: FoneAstra Flash Heated; IL: Interleukin; SD: standard deviation; IgA: Immunoglobulin A.</p>
Full article ">Figure 3
<p>Time-temperature curves of the original FH study compared to the F-FH used in this study. FH: Flash heated; F-FH: FoneAstra Flash heated.</p>
Full article ">
232 KiB  
Article
Mediterranean Diet and Its Correlates among Adolescents in Non-Mediterranean European Countries: A Population-Based Study
by Dario Novak, Lovro Štefan, Rebeka Prosoli, Arunas Emeljanovas, Brigita Mieziene, Ivana Milanović and Snežana Radisavljević-Janić
Nutrients 2017, 9(2), 177; https://doi.org/10.3390/nu9020177 - 22 Feb 2017
Cited by 42 | Viewed by 6165
Abstract
Little is known about the factors which might influence the adherence to a Mediterranean diet in non-Mediterranean European countries. Thus, the main purpose of this study was to determine the associations between socioeconomic, psychological, and physical factors on a Mediterranean diet. In this [...] Read more.
Little is known about the factors which might influence the adherence to a Mediterranean diet in non-Mediterranean European countries. Thus, the main purpose of this study was to determine the associations between socioeconomic, psychological, and physical factors on a Mediterranean diet. In this cross-sectional study, participants were 14–18-year-old adolescents (N = 3071) from two non-Mediterranean countries: Lithuania (N = 1863) and Serbia (N = 1208). The dependent variable was Mediterranean diet, and was assessed with the Mediterranean Diet Quality Index for children and adolescents questionnaire. Independent variables were gender, body-mass index, self-rated health, socioeconomic status, psychological distress, physical activity, and sedentary behavior. The associations between dependent and independent variables were analyzed by using logistic regression. Results showed that higher adherence to a Mediterranean diet was associated with higher self-rated health, socioeconomic status, and physical activity, yet low adherence to a Mediterranean diet was associated with being female, having higher body-mass index, psychological distress, and sedentary behavior. Our findings suggest that future studies need to explore associations between lifestyle habits—especially in target populations, such as primary and secondary school students. Full article
1317 KiB  
Article
Age-Related Loss in Bone Mineral Density of Rats Fed Lifelong on a Fish Oil-Based Diet Is Avoided by Coenzyme Q10 Addition
by Alfonso Varela-López, Julio J. Ochoa, José M. Llamas-Elvira, Magdalena López-Frías, Elena Planells, MCarmen Ramirez-Tortosa, Cesar L. Ramirez-Tortosa, Francesca Giampieri, Maurizio Battino and José L. Quiles
Nutrients 2017, 9(2), 176; https://doi.org/10.3390/nu9020176 - 22 Feb 2017
Cited by 25 | Viewed by 6836
Abstract
During aging, bone mass declines increasing osteoporosis and fracture risks. Oxidative stress has been related to this bone loss, making dietary compounds with antioxidant properties a promising weapon. Male Wistar rats were maintained for 6 or 24 months on diets with fish oil [...] Read more.
During aging, bone mass declines increasing osteoporosis and fracture risks. Oxidative stress has been related to this bone loss, making dietary compounds with antioxidant properties a promising weapon. Male Wistar rats were maintained for 6 or 24 months on diets with fish oil as unique fat source, supplemented or not with coenzyme Q10 (CoQ10), to evaluate the potential of adding this molecule to the n-3 polyunsaturated fatty acid (n-3 PUFA)-based diet for bone mineral density (BMD) preservation. BMD was evaluated in the femur. Serum osteocalcin, osteopontin, receptor activator of nuclear factor-κB ligand, ostroprotegerin, parathyroid hormone, urinary F2-isoprostanes, and lymphocytes DNA strand breaks were also measured. BMD was lower in aged rats fed a diet without CoQ10 respect than their younger counterparts, whereas older animals receiving CoQ10 showed the highest BMD. F2-isoprostanes and DNA strand breaks showed that oxidative stress was higher during aging. Supplementation with CoQ10 prevented oxidative damage to lipid and DNA, in young and old animals, respectively. Reduced oxidative stress associated to CoQ10 supplementation of this n-3 PUFA-rich diet might explain the higher BMD found in aged rats in this group of animals. Full article
(This article belongs to the Special Issue Antioxidants in Health and Disease)
Show Figures

Figure 1

Figure 1
<p>Effects of supplementation with coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) on plasma total CoQ<sub>10</sub> levels in 6- and 24-month-old (m) rats fed fish oil as dietary fat. Results are expressed as mean ± standard error of mean of six animals. * Statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) determined by the Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 2
<p>Effects of supplementation with coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) on bone mineral density (BMD) in 6- and 24-month-old (m) rats fed fish oil as dietary fat. Results are expressed as mean ± standard error of mean of six animals. * Statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) determined by the Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 3
<p>Effects of supplementation with coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) on urinary levels of F<sub>2</sub>-isprostanes and DNA strand breaks in lymphocytes in 6- and 24-month-old (m) rats fed fish oil as dietary fat. Results are expressed as mean ± standard error of mean of six animals. * Statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) determined by the Mann–Whitney <span class="html-italic">U</span>-test.</p>
Full article ">Figure 4
<p>Effects of supplementation with coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) on serum levels of bone metabolism markers (osteocalcin and osteopontin) in 6- and 24-month-old (m) rats fed fish oil as dietary fat. Results are expressed as mean ± standard error of mean of six animals. * Statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) determined by the Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 5
<p>Effects of supplementation with coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) on circulating levels of parathyroid hormone and adrenocorticotropin (ACTH) in 6- and 24-month-old (m) rats fed fish oil as dietary fat. Results are expressed as mean ± standard error of mean of six animals. * Statistically significant differences (<span class="html-italic">p</span> &lt; 0.05) determined by the Mann–Whitney <span class="html-italic">U</span>-test.</p>
Full article ">
735 KiB  
Article
Zinc Status Biomarkers and Cardiometabolic Risk Factors in Metabolic Syndrome: A Case Control Study
by Erika P. S. Freitas, Aline T. O. Cunha, Sephora L. S. Aquino, Lucia F. C. Pedrosa, Severina C. V. C. Lima, Josivan G. Lima, Maria G. Almeida and Karine C. M. Sena-Evangelista
Nutrients 2017, 9(2), 175; https://doi.org/10.3390/nu9020175 - 22 Feb 2017
Cited by 45 | Viewed by 8248
Abstract
Metabolic syndrome (MS) involves pathophysiological alterations that might compromise zinc status. The aim of this study was to evaluate zinc status biomarkers and their associations with cardiometabolic factors in patients with MS. Our case control study included 88 patients with MS and 37 [...] Read more.
Metabolic syndrome (MS) involves pathophysiological alterations that might compromise zinc status. The aim of this study was to evaluate zinc status biomarkers and their associations with cardiometabolic factors in patients with MS. Our case control study included 88 patients with MS and 37 controls. We performed clinical and anthropometric assessments and obtained lipid, glycemic, and inflammatory profiles. We also evaluated zinc intake, plasma zinc, erythrocyte zinc, and 24-h urinary zinc excretion. The average zinc intake was significantly lower in the MS group (p < 0.001). Regression models indicated no significant differences in plasma zinc concentration (all p > 0.05) between the two groups. We found significantly higher erythrocyte zinc concentration in the MS group (p < 0.001) independent from co-variable adjustments. Twenty-four hour urinary zinc excretion was significantly higher in the MS group (p = 0.008), and adjustments for age and sex explained 21% of the difference (R2 = 0.21, p < 0.001). There were significant associations between zincuria and fasting blood glucose concentration (r = 0.479), waist circumference (r = 0.253), triglyceride concentration (r = 0.360), glycated hemoglobin concentration (r = 0.250), homeostatic model assessment—insulin resistance (r = 0.223), and high-sensitivity C-reactive protein concentration (r = 0.427) (all p < 0.05) in the MS group. Patients with MS had alterations in zinc metabolism mainly characterized by an increase in erythrocyte zinc and higher zincuria. Full article
Show Figures

Figure 1

Figure 1
<p>Study design.</p>
Full article ">Figure 2
<p>(<b>A</b>) Forest plot for comparison of plasma zinc concentration; (<b>B</b>) erythrocytes zinc concentration; and (<b>C</b>) 24-h urinary zinc excretion between patients with MS and the control group, according to the adjustment models. Model 1: without adjustment; Model 2: adjusted for zinc intake; Model 3: adjusted for sex; Model 4: adjusted for age; Model 5: Adjusted for zinc intake and sex; Model 6: Adjusted for zinc intake and age; Model 7: adjusted for sex and age; and Model 8: Adjusted for zinc intake, sex, and age. Horizontal lines indicate the 95% confidence interval (CI) for each model. When the confidence interval does not cross the vertical axis (centered at zero), the difference in the zinc biomarker concentration among the study groups is statistically significant (<span class="html-italic">p</span> &lt; 0.05). If the confidence interval line is to the right of the central axis, it indicates that the zinc biomarker concentration is higher for patients with MS compared to the control group. In contrast, if it is on the left of the central axis, it indicates that the concentration is lower in the MS group in relation to the controls. R2: determination coefficient; ∆: estimates of the difference between patients with MS and controls, whose mean is inside the square (■); the area of each square is proportional to the variability explained by the model.</p>
Full article ">
565 KiB  
Article
A Village‐Based Intervention: Promoting Folic Acid Use among Rural Chinese Women
by Qian Lin, Lina Yang, Fang Li, Hong Qin, Mingzhi Li, Jihua Chen, Jing Deng and Xiangying Hu
Nutrients 2017, 9(2), 174; https://doi.org/10.3390/nu9020174 - 21 Feb 2017
Cited by 14 | Viewed by 6238
Abstract
Background: Folic acid supplementation is effective in reducing the risk of neural tube defects (NTDs). However, the use of folic acid is low among rural women in China. Nutrition education can provide information about folic acid and encourage its use. The primary objective [...] Read more.
Background: Folic acid supplementation is effective in reducing the risk of neural tube defects (NTDs). However, the use of folic acid is low among rural women in China. Nutrition education can provide information about folic acid and encourage its use. The primary objective of this study was to test the effectiveness of a village‐based nutrition intervention on folic acid use among rural women. Methods: Sixty villages were randomly selected using multiple‐stage sampling and were divided into control and intervention groups. The intervention included nutritional education at village clinics, written materials, and text messages (SMS). Folic acid use knowledge and behavior was assessed at baseline and after the intervention. Results: Self‐reported compliance with folic acid supplement use increased from 17.0%–29.2% at baseline to 41.7%-59.2% one year post‐intervention. During the same period, the folic acid knowledge score in the intervention group increased from 3.07 to 3.65, significantly higher than the control group (3.11 to 3.35). Multivariate binary logistic regression showed that the women who received folic acid education and SMS intervention were more likely to comply with folic acid supplement recommendations. Conclusions: The results indicated that an integrated village‐based folic acid education intervention may be an effective way of promoting folic acid use for the prevention of NTDs in rural women. Full article
Show Figures

Figure 1

Figure 1
<p>Pathway of the intervention and primary outcome. FA: folic acid; NTD: neural tube defect.</p>
Full article ">
3370 KiB  
Article
The Effects of Moderate Whole Grain Consumption on Fasting Glucose and Lipids, Gastrointestinal Symptoms, and Microbiota
by Danielle N. Cooper, Mary E. Kable, Maria L. Marco, Angela De Leon, Bret Rust, Julita E. Baker, William Horn, Dustin Burnett and Nancy L. Keim
Nutrients 2017, 9(2), 173; https://doi.org/10.3390/nu9020173 - 21 Feb 2017
Cited by 42 | Viewed by 14671
Abstract
This study was designed to determine if providing wheat, corn, and rice as whole (WG) or refined grains (RG) under free-living conditions will change parameters of health over a six-week intervention in healthy, habitual non-WG consumers. Measurements of body composition, fecal microbiota, fasting [...] Read more.
This study was designed to determine if providing wheat, corn, and rice as whole (WG) or refined grains (RG) under free-living conditions will change parameters of health over a six-week intervention in healthy, habitual non-WG consumers. Measurements of body composition, fecal microbiota, fasting blood glucose, total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), and triglycerides were made at baseline and post intervention. Subjects were given adequate servings of either WG or RG products based on their caloric need and asked to keep records of grain consumption, bowel movements, and GI symptoms weekly. After six weeks, subjects repeated baseline testing. Significant decreases in total, LDL, and non-HDL cholesterol were seen after the WG treatments but were not observed in the RG treatment. During Week 6, bowel movement frequency increased with increased WG consumption. No significant differences in microbiota were seen between baseline and post intervention, although, abundance of order Erysipelotrichales increased in RG subjects who ate more than 50% of the RG market basket products. Increasing consumption of WGs can alter parameters of health, but more research is needed to better elucidate the relationship between the amount consumed and the health-related outcome. Full article
(This article belongs to the Special Issue Dietary Fibers and Human Health)
Show Figures

Figure 1

Figure 1
<p>Range of Market Basket Consumption. Consumption of the refined grain market basket ranged from 1.1% to 95.1% with the average consumption being 44.7% and a standard error of the mean of 7.8. Consumption of the whole grain market basket ranged from 18.1% to 97.5% with the average consumption being 47.9% and a standard error of the mean of 3.0.</p>
Full article ">Figure 2
<p>Changes in Body Composition with Percent Consumption of the Market Baskets. No significant differences were found using analysis of variance in the change of BMI (RG <span class="html-italic">p</span> = 0.494, WG <span class="html-italic">p</span> = 0.658), fat mass (RG <span class="html-italic">p</span> = 0.962, WG <span class="html-italic">p</span> = 0.372), or fat free mass (RG <span class="html-italic">p</span> = 0.823, WG <span class="html-italic">p</span> = 0.561) from baseline to post intervention.</p>
Full article ">Figure 3
<p>Percent of Market Basket Consumed Related to Change in Fasting Glucose. Increased consumption of the whole grain market basket was related to lower (<span class="html-italic">p</span> = 0.053) fasting blood glucose in the whole grain treatment, whereas there was a pattern of increased blood glucose with increased consumption of the refined grain market basket (<span class="html-italic">p</span> = 0.590).</p>
Full article ">Figure 4
<p>Consumption of the Whole or Refined Grain Market Basket Related to Change in Fasting Total, LDL, and Non-HDL Cholesterol. Consumption of the WG market basket was significantly associated with lower fasting levels of total cholesterol (<span class="html-italic">p</span> = 0.018), LDL cholesterol (<span class="html-italic">p</span> = 0.035), and non-HDL cholesterol (<span class="html-italic">p</span> = 0.047) when compared to subjects that consumed the RG market basket.</p>
Full article ">Figure 5
<p>Percent of market basket consumed related to bowel movement frequency. The association between bowel movement frequency and percent of market basket consumed for refined grain consumers (<b>left</b> panel) and whole grain consumers (<b>right</b> panel) as determined by logistical regression and Wilcoxon Rank Sum testing. The refined grain treatment represents data from ten subjects; the whole grain treatment represents data from 27 subjects. There is a significant positive association with whole grain consumption (<span class="html-italic">p</span> = 0.046), but not with refined grain consumption (<span class="html-italic">p</span> = 0.407).</p>
Full article ">Figure 6
<p>Relative proportion of taxa in each experimental group. The relative proportion of taxa at baseline (B) and post intervention (P) for the refined grain (RG) and whole (WG) treatments: (<b>a</b>) the relative proportion of bacteria at the phylum level; and (<b>b</b>) the relative abundance of bacteria at the most specific level of classification available. In both panels, taxa present at a median of 1% relative abundance in the data set are shown. Taxa present at lower than 1% median relative abundance are grouped into the “Other” category.</p>
Full article ">Figure 7
<p>Variation in specific taxa during market basket consumption. Log2 fold change in abundance of bacteria at either high (50% or more) or low (49.99% or less) levels of consumption of the market baskets from baseline to post intervention for: refined grain (<b>a</b>); and whole grain (<b>b</b>). Taxa shown were present in at least 2% relative abundance in at least one sample. Dots seen in the graphs represent outliers. The findings of interest were an increase in the relative abundance of <span class="html-italic">Akkermansia</span> and <span class="html-italic">Lactobacillus</span> with high whole grain market basket consumption and a decrease with high refined grain consumption, as well as the increased abundance of the order <span class="html-italic">Erysipelotrichales</span> (<span class="html-italic">p</span> = 0.023) with high refined grain consumption.</p>
Full article ">Figure 8
<p>Images of the 2000 kcal market baskets: (<b>a</b>) the refined grain basket; and (<b>b</b>) the whole grain basket.</p>
Full article ">
246 KiB  
Article
Validity and Reliability of General Nutrition Knowledge Questionnaire for Adults in Uganda
by Richard Bukenya, Abhiya Ahmed, Jeanette M. Andrade, Diana S. Grigsby-Toussaint, John Muyonga and Juan E. Andrade
Nutrients 2017, 9(2), 172; https://doi.org/10.3390/nu9020172 - 21 Feb 2017
Cited by 26 | Viewed by 9438
Abstract
This study sought to develop and validate a general nutrition knowledge questionnaire (GNKQ) for Ugandan adults. The initial draft consisted of 133 items on five constructs associated with nutrition knowledge; expert recommendations (16 items), food groups (70 items), selecting food (10 items), nutrition [...] Read more.
This study sought to develop and validate a general nutrition knowledge questionnaire (GNKQ) for Ugandan adults. The initial draft consisted of 133 items on five constructs associated with nutrition knowledge; expert recommendations (16 items), food groups (70 items), selecting food (10 items), nutrition and disease relationship (23 items), and food fortification in Uganda (14 items). The questionnaire validity was evaluated in three studies. For the content validity (study 1), a panel of five content matter nutrition experts reviewed the GNKQ draft before and after face validity. For the face validity (study 2), head teachers and health workers (n = 27) completed the questionnaire before attending one of three focus groups to review the clarity of the items. For the construct and test-rest reliability (study 3), head teachers (n = 40) from private and public primary schools and nutrition (n = 52) and engineering (n = 49) students from Makerere University took the questionnaire twice (two weeks apart). Experts agreed (content validity index, CVI > 0.9; reliability, Gwet’s AC1 > 0.85) that all constructs were relevant to evaluate nutrition knowledge. After the focus groups, 29 items were identified as unclear, requiring major (n = 5) and minor (n = 24) reviews. The final questionnaire had acceptable internal consistency (Cronbach α > 0.95), test-retest reliability (r = 0.89), and differentiated (p < 0.001) nutrition knowledge scores between nutrition (67 ± 5) and engineering (39 ± 11) students. Only the construct on nutrition recommendations was unreliable (Cronbach α = 0.51, test-retest r = 0.55), which requires further optimization. The final questionnaire included topics on food groups (41 items), selecting food (2 items), nutrition and disease relationship (14 items), and food fortification in Uganda (22 items) and had good content, construct, and test-retest reliability to evaluate nutrition knowledge among Ugandan adults. Full article
3015 KiB  
Article
Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges
by Pathum Dhanapala, Dulashi Withanage-Dona, Mimi L. K. Tang, Tim Doran and Cenk Suphioglu
Nutrients 2017, 9(2), 171; https://doi.org/10.3390/nu9020171 - 21 Feb 2017
Cited by 21 | Viewed by 6315
Abstract
Background: Gal d 1 (ovomucoid) is the dominant allergen in the chicken egg white. Hypoallergenic variants of this allergen can be used in immunotherapy as an egg allergy treatment approach. We hypothesised that disruption of two of the nine cysteine-cysteine bridges by site-directed [...] Read more.
Background: Gal d 1 (ovomucoid) is the dominant allergen in the chicken egg white. Hypoallergenic variants of this allergen can be used in immunotherapy as an egg allergy treatment approach. We hypothesised that disruption of two of the nine cysteine-cysteine bridges by site-directed mutagenesis will allow the production of a hypoallergenic variant of the protein; Methods: Two cysteine residues at C192 and C210 in domain III of the protein were mutated to alanine using site-directed mutagenesis, to disrupt two separate cysteine-cysteine bridges. The mutated and non-mutated proteins were expressed in Escherichia coli (E. coli) by induction with isopropyl β-d-1-thiogalactopyranoside (IPTG). The expressed proteins were analysed using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting to confirm expression. Immunoglobulin E (IgE) reactivity of the two proteins was analysed, by immunoblotting, against a pool of egg-allergic patients’ sera. A pool of non-allergic patients’ sera was also used in a separate blot as a negative control; Results: Mutant Gal d 1 showed diminished IgE reactivity in the immunoblot by showing lighter bands when compared to the non-mutated version, although there was more of the mutant protein immobilised on the membrane when compared to the wild-type protein. The non-allergic negative control showed no bands, indicating an absence of non-specific binding of secondary antibody to the proteins; Conclusion: Disruption of two cysteine bridges in domain III of Gal d 1 reduces IgE reactivity. Following downstream laboratory and clinical testing, this mutant protein can be used in immunotherapy to induce tolerance to Gal d 1 and in egg allergy diagnosis. Full article
(This article belongs to the Special Issue Nutrition and Allergic Diseases)
Show Figures

Figure 1

Figure 1
<p>The nucleotide and amino acid sequence of Gal d 1. The squared cysteine (C) residues at positions C192 and C210 are the targeted residues. These were replaced with alanine by mutating the nucleotides to GCC.</p>
Full article ">Figure 2
<p>The secondary structure of Gal d 1 showing the total number of cysteine bridges. The two arrows show the two cysteine bridges that would be destroyed by the mutations shown in <a href="#nutrients-09-00171-f001" class="html-fig">Figure 1</a>. Figure adapted from: Kato et al., 1987 [<a href="#B1-nutrients-09-00171" class="html-bibr">1</a>].</p>
Full article ">Figure 3
<p>Time-course expression of the mutant Gal d 1. A time-course expression of the wild-type Gal d 1 (<b>A</b>) was previously published in Dhanapala et al. 2015 [<a href="#B20-nutrients-09-00171" class="html-bibr">20</a>]. The mutant Gal d 1 (<b>B</b>) was subjected to a time-course expression to determine its optimal expression time and conditions and was compared to the wild-type Gal d 1 expression shown in (<b>A</b>).</p>
Full article ">Figure 4
<p>Immunoblot comparison of the wild-type and mutant Gal d 1 immobilised on nitrocellulose. Three Western blots were conducted using His-tag–specific antibodies (Tetra-His &amp; Penta-His) and anti-Xpress antibody to compare the expression level of wild-type and mutant (PM7/9) Gal d 1. SDS-PAGE shows the profile of the loaded proteins.</p>
Full article ">Figure 5
<p>Immunological comparison of IgE reactivity of wild-type and mutant Gal d 1. Western blots were conducted, with exactly the same amount of proteins loaded against egg-allergic and non-allergic patients’ sera. Anti-human IgE produced in goat was used as the secondary antibody. Non-allergic controls were used to test for any non-specific binding of secondary antibody. The blots show a loss of IgE reactivity in the mutant PM7/9.</p>
Full article ">
254 KiB  
Article
Calcium Intake and Nutritional Adequacy in Spanish Children: The ANIVA Study
by Nuria Rubio-López, Agustín Llopis-González and María Morales-Suárez-Varela
Nutrients 2017, 9(2), 170; https://doi.org/10.3390/nu9020170 - 21 Feb 2017
Cited by 12 | Viewed by 6823
Abstract
Calcium is an important nutrient for child development. The main objective of this study was to assess calcium intake and its adequacy with dietary reference intake (DRI) in Spanish children. The ANIVA (Antropometría y Nutrición Infantil de Valencia) study is a descriptive cross-sectional [...] Read more.
Calcium is an important nutrient for child development. The main objective of this study was to assess calcium intake and its adequacy with dietary reference intake (DRI) in Spanish children. The ANIVA (Antropometría y Nutrición Infantil de Valencia) study is a descriptive cross-sectional study. During two academic years 2013–2014 and 2014–2015, 1176 schoolchildren aged 6–9 years were selected from 14 primary schools in Valencia (Spain). Three-day food records were used to assess dietary intake, completed by parents/guardian. Anthropometric data (weight and height) were evaluated in all subjects. Nutritional intake was compared to estimated average requirements (EARs) and adequate intake (AI) values to determine nutritional adequacy. A percentage of 25.77% had inadequate calcium intake, and a significantly higher prevalence was observed in girls (p = 0.006). Adequate calcium intake showed a positive association with the height z-score (p = 0.032). When assessing dietary patterns, schoolchildren with adequate calcium intakes had better nutritional adequacy in all nutrients, except cholesterol (p = 0.086) and fluorine (p = 0.503). These results suggest a public health problem that must be addressed through nutrition education programs to increase intake of calcium-rich food and to correct the associated dietary pattern. Full article
283 KiB  
Article
‘Dose-to-Mother’ Deuterium Oxide Dilution Technique: An Accurate Strategy to Measure Vitamin A Intake in Breastfed Infants
by Veronica Lopez-Teros, Ana Teresa Limon-Miro, Humberto Astiazaran-Garcia, Sherry A. Tanumihardjo, Orlando Tortoledo-Ortiz and Mauro E. Valencia
Nutrients 2017, 9(2), 169; https://doi.org/10.3390/nu9020169 - 21 Feb 2017
Cited by 15 | Viewed by 6320
Abstract
In Mexico, infants (0–2 years old) show the highest prevalence of vitamin A deficiency (VAD), measured by serum retinol concentrations. Thus, we consider that low vitamin A (VA) intake through breast milk (BM) combined with poor weaning practices are the main factors that [...] Read more.
In Mexico, infants (0–2 years old) show the highest prevalence of vitamin A deficiency (VAD), measured by serum retinol concentrations. Thus, we consider that low vitamin A (VA) intake through breast milk (BM) combined with poor weaning practices are the main factors that contribute to VAD in this group. We combined the assessment of VA status in lactating women using BM retinol and a stable isotope ‘dose-to-mother’ technique to measure BM production in women from urban and agricultural areas. Infants’ mean BM intake was 758 ± 185 mL, and no difference was observed between both areas (p = 0.067). Mean BM retinol concentration was 1.09 μmol/L, which was significantly lower for the agricultural area (p = 0.028). Based on BM retinol concentration, 57% of women were VAD; although this prevalence fell to 16% when based on fat content. Regardless of the VA biomarker used here, infants from the urban and agricultural areas cover only 66% and 49% of their dietary adequate intake from BM, respectively (p = 0.054). Our data indicate that VAD is still a public health concern in Mexico. Adopting both methods to assess VA transfer from the mother to the breastfed child offers an innovative approach towards the nutritional assessment of vulnerable groups. Full article
(This article belongs to the Special Issue Vitamin A Update 2016)
733 KiB  
Article
Reported Dietary Intake, Disparity between the Reported Consumption and the Level Needed for Adequacy and Food Sources of Calcium, Phosphorus, Magnesium and Vitamin D in the Spanish Population: Findings from the ANIBES Study †
by Josune Olza, Javier Aranceta-Bartrina, Marcela González-Gross, Rosa M. Ortega, Lluis Serra-Majem, Gregorio Varela-Moreiras and Ángel Gil
Nutrients 2017, 9(2), 168; https://doi.org/10.3390/nu9020168 - 21 Feb 2017
Cited by 107 | Viewed by 14064
Abstract
Calcium, phosphorus, magnesium and vitamin D have important biological roles in the body, especially in bone metabolism. We aimed to study the reported intake, the disparity between the reported consumption and the level needed for adequacy and food sources of these four nutrients [...] Read more.
Calcium, phosphorus, magnesium and vitamin D have important biological roles in the body, especially in bone metabolism. We aimed to study the reported intake, the disparity between the reported consumption and the level needed for adequacy and food sources of these four nutrients in the Spanish population. We assessed the reported intake for both, general population and plausible reporters. Results were extracted from the ANIBES survey, n = 2009. Three-day dietary reported intake data were obtained and misreporting was assessed according to the European Food Safety Authority (EFSA). Mean ± SEM (range) total reported consumption of calcium, phosphorus, magnesium, and vitamin D for the whole population were 698 ± 7 mg/day (71–2551 mg/day), 1176 ± 8 mg/day, (331–4429 mg/day), 222 ± 2 mg/day (73–782 mg/day), and 4.4 ± 0.1 µg/day (0.0–74.2 µg/day), respectively. In the whole group, 76% and 66%; 79% and 72%; and 94% and 93% of the population had reported intakes below 80% of the national and European recommended daily intakes for calcium, magnesium and vitamin D, respectively; these percentages were over 40% when the plausible reporters were analysed separately. The main food sources were milk and dairy products for calcium and phosphorus, cereals and grains for magnesium and fish for vitamin D. In conclusion, there is an important percentage of the Spanish ANIBES population not meeting the recommended intakes for calcium, magnesium and vitamin D. Full article
Show Figures

Figure 1

Figure 1
<p>Contribution of food categories to the daily calcium, phosphorus, magnesium and vitamin D reported intake in the ANIBES Study population.</p>
Full article ">
2235 KiB  
Article
Metabolic Effects of Glucose-Fructose Co-Ingestion Compared to Glucose Alone during Exercise in Type 1 Diabetes
by Lia Bally, Patrick Kempf, Thomas Zueger, Christian Speck, Nicola Pasi, Carlos Ciller, Katrin Feller, Hannah Loher, Robin Rosset, Matthias Wilhelm, Chris Boesch, Tania Buehler, Ayse S. Dokumaci, Luc Tappy and Christoph Stettler
Nutrients 2017, 9(2), 164; https://doi.org/10.3390/nu9020164 - 21 Feb 2017
Cited by 13 | Viewed by 8831
Abstract
This paper aims to compare the metabolic effects of glucose-fructose co-ingestion (GLUFRU) with glucose alone (GLU) in exercising individuals with type 1 diabetes mellitus. Fifteen male individuals with type 1 diabetes (HbA1c 7.0% ± 0.6% (53 ± 7 mmol/mol)) underwent a 90 min [...] Read more.
This paper aims to compare the metabolic effects of glucose-fructose co-ingestion (GLUFRU) with glucose alone (GLU) in exercising individuals with type 1 diabetes mellitus. Fifteen male individuals with type 1 diabetes (HbA1c 7.0% ± 0.6% (53 ± 7 mmol/mol)) underwent a 90 min iso-energetic continuous cycling session at 50% VO2max while ingesting combined glucose-fructose (GLUFRU) or glucose alone (GLU) to maintain stable glycaemia without insulin adjustment. GLUFRU and GLU were labelled with 13C-fructose and 13C-glucose, respectively. Metabolic assessments included measurements of hormones and metabolites, substrate oxidation, and stable isotopes. Exogenous carbohydrate requirements to maintain stable glycaemia were comparable between GLUFRU and GLU (p = 0.46). Fat oxidation was significantly higher (5.2 ± 0.2 vs. 2.6 ± 1.2 mg·kg−1·min−1, p < 0.001) and carbohydrate oxidation lower (18.1 ± 0.8 vs. 24.5 ± 0.8 mg·kg−1·min−1 p < 0.001) in GLUFRU compared to GLU, with decreased muscle glycogen oxidation in GLUFRU (10.2 ± 0.9 vs. 17.5 ± 1.0 mg·kg−1·min−1, p < 0.001). Lactate levels were higher (2.2 ± 0.2 vs. 1.8 ± 0.1 mmol/L, p = 0.012) in GLUFRU, with comparable counter-regulatory hormones between GLUFRU and GLU (p > 0.05 for all). Glucose and insulin levels, and total glucose appearance and disappearance were comparable between interventions. Glucose-fructose co-ingestion may have a beneficial impact on fuel metabolism in exercising individuals with type 1 diabetes without insulin adjustment, by increasing fat oxidation whilst sparing glycogen. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Carbohydrate administration during first, second, and third 30 min-intervals of exercise. GLUFRU (glucose-fructose co-ingestion) = dark grey bar and GLU (glucose alone ingestion) = light grey bar. Results are expressed as mean ± SEM.</p>
Full article ">Figure 2
<p>Measured blood glucose and insulin during GLUFRU (black circle) and GLU (white circle). Left to right: blood glucose, <span class="html-italic">p</span> = 0.67; insulin, <span class="html-italic">p</span> = 0.89. Results are expressed as mean ± SEM.</p>
Full article ">Figure 3
<p>Measured hormones and metabolites during GLUFRU (black circle) and GLU (white circle). Clockwise from top left: lactate, <span class="html-italic">p</span> = 0.012; non-esterified fatty acids (NEFAs), <span class="html-italic">p</span> = 0.43; growth hormone, <span class="html-italic">p</span> = 0.50; adrenaline, <span class="html-italic">p</span> = 0.39; dopamine, <span class="html-italic">p</span> = 0.037; cortisol, <span class="html-italic">p</span> = 0.54; noradrenaline, <span class="html-italic">p</span> = 0.45; glucagon, <span class="html-italic">p</span> = 0.16. Results are expressed as mean ± SEM.</p>
Full article ">Figure 3 Cont.
<p>Measured hormones and metabolites during GLUFRU (black circle) and GLU (white circle). Clockwise from top left: lactate, <span class="html-italic">p</span> = 0.012; non-esterified fatty acids (NEFAs), <span class="html-italic">p</span> = 0.43; growth hormone, <span class="html-italic">p</span> = 0.50; adrenaline, <span class="html-italic">p</span> = 0.39; dopamine, <span class="html-italic">p</span> = 0.037; cortisol, <span class="html-italic">p</span> = 0.54; noradrenaline, <span class="html-italic">p</span> = 0.45; glucagon, <span class="html-italic">p</span> = 0.16. Results are expressed as mean ± SEM.</p>
Full article ">Figure 4
<p>Carbohydrate (CHO) and fat oxidation during GLUFRU (black circle) and GLU (white circle). Results are expressed as mean ± SEM. Left to right: CHO oxidation, <span class="html-italic">p</span> &lt; 0.001; fat oxidation, <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">
2573 KiB  
Review
Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications
by Sirichai Adisakwattana
Nutrients 2017, 9(2), 163; https://doi.org/10.3390/nu9020163 - 21 Feb 2017
Cited by 217 | Viewed by 16075
Abstract
With recent insight into the development of dietary supplements and functional foods, search of effective phytochemical compounds and their mechanisms involved in prevention and management of diabetes and its complications are now being assessed. Cinnamic acid and its derivatives occur naturally in high [...] Read more.
With recent insight into the development of dietary supplements and functional foods, search of effective phytochemical compounds and their mechanisms involved in prevention and management of diabetes and its complications are now being assessed. Cinnamic acid and its derivatives occur naturally in high levels of plant-based foods. Among various biological activities, cinnamic acid and its derivatives are associated with a beneficial influence on diabetes and its complications. The aim of the review is to summarize the potential mechanisms of these compounds for prevention and management of diabetes and its complications. Based on several in vitro studies and animal models, cinnamic acid and its derivatives act on different mechanism of actions, including stimulation of insulin secretion, improvement of pancreatic β-cell functionality, inhibition of hepatic gluconeogenesis, enhanced glucose uptake, increased insulin signaling pathway, delay of carbohydrate digestion and glucose absorption, and inhibition of protein glycation and insulin fibrillation. However, due to the limited intestinal absorption being a result of low bioavailability of cinnamic acid and its derivatives, current improvement efforts with entrapping into solid and liquid particles are highlighted. Further human clinical studies are needed to clarify the effects of cinnamic acid and its derivatives in diabetic patients. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The chemical structure of cinnamic acid and its derivatives. (<b>A</b>) Cinnamic acid; (<b>B</b>) <span class="html-italic">o</span>-Hydroxycinnamic acid; (<b>C</b>) <span class="html-italic">m</span>- Hydroxycinnamic acid; (<b>D</b>) <span class="html-italic">p</span>- Hydroxycinnamic acid; (<b>E</b>) <span class="html-italic">o</span>-Methoxycinnamic acid; (<b>F</b>) <span class="html-italic">m</span>-Methoxycinnamic acid; (<b>G</b>) <span class="html-italic">p</span>-Methoxycinnamic acid; (<b>H</b>) Ferulic acid (<b>I</b>) Isoferulic acid; (<b>J</b>) Caffeic acid.</p>
Full article ">Figure 2
<p>Schematic diagram represents the mechanism actions of cinnamic acid and its derivatives for prevention and management of diabetes and its complication. (↑) Increase, (↓) Decrease.</p>
Full article ">Figure 3
<p>Mechanisms of ferulic acid, caffeic acid, <span class="html-italic">p</span>-hydroxycinnamic acid, cinnamic acid, and isoferulic acid for stimulating glucose uptake in adipocytes and muscle.</p>
Full article ">Figure 4
<p>Inhibition of carbohydrate digestive enzymes (pancreatic α-amylase, maltase, and sucrase) and monosaccharide absorption (GLUT2) by ferulic acid, isoferulic acid, and caffeic acid.</p>
Full article ">Figure 5
<p>Graphical presentation of possible anti-glycation mechanisms of cinnamic acid and its derivatives.</p>
Full article ">Figure 6
<p>The mechanism of ferulic acid and isoferulic acid on prevention of methylglyoxal-induced protein and DNA damage.</p>
Full article ">
1887 KiB  
Article
Fructose and Sucrose Intake Increase Exogenous Carbohydrate Oxidation during Exercise
by Jorn Trommelen, Cas J. Fuchs, Milou Beelen, Kaatje Lenaerts, Asker E. Jeukendrup, Naomi M. Cermak and Luc J. C. Van Loon
Nutrients 2017, 9(2), 167; https://doi.org/10.3390/nu9020167 - 20 Feb 2017
Cited by 35 | Viewed by 19129
Abstract
Peak exogenous carbohydrate oxidation rates typically reach ~1 g∙min−1 during exercise when ample glucose or glucose polymers are ingested. Fructose co‐ingestion has been shown to further increase exogenous carbohydrate oxidation rates. The purpose of this study was to assess the impact of fructose [...] Read more.
Peak exogenous carbohydrate oxidation rates typically reach ~1 g∙min−1 during exercise when ample glucose or glucose polymers are ingested. Fructose co‐ingestion has been shown to further increase exogenous carbohydrate oxidation rates. The purpose of this study was to assess the impact of fructose co‐ingestion provided either as a monosaccharide or as part of the disaccharide sucrose on exogenous carbohydrate oxidation rates during prolonged exercise in trained cyclists. Ten trained male cyclists (VO2peak: 65 ± 2 mL∙kg−1∙min−1) cycled on four different occasions for 180 min at 50% Wmax during which they consumed a carbohydrate solution providing 1.8 g∙min−1 of glucose (GLU), 1.2 g∙min−1 glucose + 0.6 g∙min−1 fructose (GLU + FRU), 0.6 g∙min−1 glucose + 1.2 g∙min−1 sucrose (GLU + SUC), or water (WAT). Peak exogenous carbohydrate oxidation rates did not differ between GLU + FRU and GLU + SUC (1.40 ± 0.06 vs. 1.29 ± 0.07 g∙min−1, respectively, p = 0.999), but were 46% ± 8% higher when compared to GLU (0.96 ± 0.06 g∙min−1: p < 0.05). In line, exogenous carbohydrate oxidation rates during the latter 120 min of exercise were 46% ± 8% higher in GLU + FRU or GLU + SUC compared with GLU (1.19 ± 0.12, 1.13 ± 0.21, and 0.82 ± 0.16 g∙min−1, respectively, p < 0.05). We conclude that fructose co‐ingestion (0.6 g∙min−1) with glucose (1.2 g∙min−1) provided either as a monosaccharide or as sucrose strongly increases exogenous carbohydrate oxidation rates during prolonged exercise in trained cyclists. Full article
Show Figures

Figure 1

Figure 1
<p>Breath <sup>13</sup>CO<sub>2</sub> enrichments (<b>A</b>) and exogenous carbohydrate oxidation rates (<b>B</b>) during exercise without ingestion of carbohydrate (WAT), with the ingestion of glucose (GLU), with the ingestion of glucose and fructose (GLU + FRU), or with the ingestion of glucose and sucrose (GLU + SUC). Data were analsysed with a two-way repeated measures ANOVA (time-treatment). Data are presented as means ± SEM. <span class="html-italic">N</span> = 10. a, denotes GLU significantly different from WAT; b, denotes GLU + FRU significantly different from WAT; c, denotes GLU + SUC significantly different from WAT; d, denotes GLU + FRU significantly different from GLU; e, denotes GLU + SUC significantly different from GLU (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>Relative contribution of substrates to total energy expenditure calculated for the 60- to 180 min period of exercise without the ingestion of carbohydrate (WAT), with the ingestion of glucose (GLU), with the ingestion of glucose and fructose (GLU + FRU), or with the ingestion of glucose and sucrose (GLU + SUC). Data were analsysed with a repeated measures ANOVA (treatment). Data are presented as means ± SEM. <span class="html-italic">N</span> = 10; b, denotes GLU + FRU significantly different from WAT; c, denotes GLU + SUC significantly different from WAT; d, denotes GLU + FRU significantly different from GLU; e, denotes GLU + SUC significantly different from GLU (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Plasma glucose (<b>A</b>), insulin (<b>B</b>), and lactate (<b>C</b>) concentrations during exercise without ingestion of carbohydrate (WAT), with the ingestion of glucose (GLU), with the ingestion of glucose and fructose (GLU + FRU), or with the ingestion of glucose and sucrose (GLU + SUC). Data were analsysed with a two-way repeated measures ANOVA (time-treatment). Data are presented as means ± SEM. <span class="html-italic">N</span> = 10; a, denotes GLU significantly different from WAT; b, denotes GLU + FRU significantly different from WAT; c, denotes GLU + SUC significantly different from WAT; d, denotes GLU + FRU significantly different from GLU; e, denotes GLU + SUC significantly different from GLU (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Plasma I-FABP concentrations during exercise (<b>A</b>) and (area under the curve (AUC) of percentage I-FABP change during exercise (<b>B</b>) without ingestion of carbohydrate (WAT), with the ingestion of glucose (GLU), with the ingestion of glucose and fructose (GLU + FRU), or with the ingestion of glucose and sucrose (GLU + SUC). Plasma I-FABP (A) was analsysed with a two-way repeated measures ANOVA (time-treatment). Plasma I-FABP iAUC was analysed with a repeated measures ANOVA (treatment). Data are presented as means ± SEM. <span class="html-italic">N</span> = 10. Differences between treatments did not reach statistical significance (<span class="html-italic">p</span> &gt; 0.05).</p>
Full article ">
4082 KiB  
Article
S‐Allylmercaptocysteine Attenuates Cisplatin‐Induced Nephrotoxicity through Suppression of Apoptosis, Oxidative Stress, and Inflammation
by Xiaosong Zhu, Xiaoyan Jiang, Ang Li, Zhongxi Zhao and Siying Li
Nutrients 2017, 9(2), 166; https://doi.org/10.3390/nu9020166 - 20 Feb 2017
Cited by 66 | Viewed by 5798
Abstract
Cisplatin is a potent chemotherapeutic agent, but its clinical usage is limited by nephrotoxicity. S‐allylmercaptocysteine (SAMC), one of the water‐soluble organosulfur garlic derivatives, has antioxidant and anti‐inflammatory properties and plays an important role in protecting cells from apoptosis. This study aims to examine [...] Read more.
Cisplatin is a potent chemotherapeutic agent, but its clinical usage is limited by nephrotoxicity. S‐allylmercaptocysteine (SAMC), one of the water‐soluble organosulfur garlic derivatives, has antioxidant and anti‐inflammatory properties and plays an important role in protecting cells from apoptosis. This study aims to examine the protective effects of SAMC on cisplatin nephrotoxicity and to explore the mechanism of its renoprotection. Rats were treated with cisplatin with or without pre‐treatment with SAMC. Renal function, histological change, oxidative stress markers and antioxidant enzyme activities were investigated. Apoptotic marker, nuclearfactor (NF)‐κB activity, expression of nuclear factor erythroid 2‐related factor 2 (Nrf2), NAD(P)H:quinone oxidoreductase 1 (NQO1) and inflammatory cytokines were also examined. The effect of SAMC on cell viability and apoptosis was examined in cultured human kidney (HK‐2) cells. SAMC was confirmed to significantly attenuate cisplatin‐induced renal damage by using histological pathology and molecular biological method. Pre‐treatment with SAMC reduced NF‐κB activity, up‐regulated Nrf2 and NQO1 expression and down‐regulated inflammatory cytokine levels after cisplatin administration. Cisplatin‐induced apoptosis in HK‐2 cells was significantly attenuated by SAMC. Thus our results suggest that SAMC could be a potential therapeutic agent in the treatment of the cisplatin‐induced nephrotoxicity through its anti‐apoptotic, anti‐oxidant and anti‐inflammatory effects. Full article
Show Figures

Figure 1

Figure 1
<p>S-allylmercaptocysteine (SAMC) attenuated cisplatin-induced cytotoxicity in human kidney (HK-2) cells. Cell viability was assessed using the SRB (sulphorhodamine B) assay. HK-2 cells were treated with various concentrations of cisplatin (<b>A</b>), SAMC (<b>B</b>), Cells were pretreated with or without SAMC (50–100 μM) for 4 h and then cultured in the presence or absence of 8 μg/mL cisplatin for 24 h (<b>C</b>,<b>D</b>) HK-2 cells treated with 8 μg/mL cisplatin and 8 μg/mL cisplatin plus 100 μM SAMC were stained with DAPI (4’6-diamidino-2-phenylindole) to investigate apoptotic-like nuclear morphology. White arrows indicate condensed nuclei. All data were obtained from three independent experiments and presented as the means ± SEM (standard error of the mean). Bars with different characters are statistically different at * <span class="html-italic">p</span> &lt; 0.05 level.</p>
Full article ">Figure 2
<p>SAMC rescued HK-2 cells from cisplatin-induced apoptosis. (<b>A</b>,<b>B</b>) SAMC decreased cisplatin-induced apoptotic cell death. Cells were pretreated with or without 100 μM SAMC for 4 h and then cultured in the presence or absence of 8 μg/mL cisplatin for 24 h. ** <span class="html-italic">p</span> &lt; 0.01 vs. control, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. cisplatin.</p>
Full article ">Figure 3
<p>Effects of SAMC on nuclear factor erythroid 2-related factor 2 (Nrf2) and NAD(P)H:quinone oxidoreductase 1 (NQO1) expression (<b>A</b>); NF-κB activity and the expression of apoptosis-related proteins (<b>B</b>) in HK-2 cells. Cells were pretreated with or without SAMC (50–100 μM) for 4 h and then cultured in the presence or absence of 8 μg/mL cisplatin for 24 h. The expression levels of Nrf2, NQO1, IκBα, Bcl-2, p53, cytochrome c and cleaved PARP (poly ADP ribose polymerase) were analyzed by Western blot. Equal protein loading was confirmed by analysis of β-actin in the protein extracts.</p>
Full article ">Figure 4
<p>Effect of SAMC on cisplatin-induced changes in serum renal function parameters. (<b>A</b>) Blood urea nitrogen (BUN); (<b>B</b>) Creatinine; (<b>C</b>) Percentage change in body weight and (<b>D</b>) Relative weight of kidneys in different experimental groups. SAMC was administered intraperitoneally at three different doses i.e., 10 mg/kg, 20 mg/kg and 30 mg/kg for 20 consecutive days and a single dose of cisplatin (7 mg/kg, intraperitoneally) was administered on the 15th day. On the 20th day, serum levels of BUN and creatinine, percentage change in body weight and relative weight of kidneys were recorded. Values are expressed as mean ± SEM (<span class="html-italic">n</span> = 6). ** <span class="html-italic">p</span>&lt; 0.01 vs. control, <sup>#</sup> <span class="html-italic">p</span>&lt; 0.05 vs. cisplatin.</p>
Full article ">Figure 5
<p>Effect of SAMC on renal histology (<b>A</b>) and tubular apoptosis (<b>B</b>) in cisplatin-induced renal injury in rats. White arrows show tubular damage.</p>
Full article ">Figure 6
<p>Effect of SAMC on cisplatin-induced changes in antioxidant enzymes activities in renal tissues of rats. (<b>A</b>) Catalase; (<b>B</b>) Superoxide dismutase. SAMC was administered intraperitoneally at three different doses, i.e., 10 mg/kg, 20 mg/kg and 30 mg/kg for 20 consecutive days and a single dose of cisplatin (7 mg/kg, i.p) was administered on the 15th day. Values are expressed as mean ± SEM (<span class="html-italic">n</span> = 6). * <span class="html-italic">p</span> &lt; 0.05 vs. control, ** <span class="html-italic">p</span> &lt; 0.01 vs. control, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. cisplatin.</p>
Full article ">Figure 7
<p>Effect of SAMC on cisplatin-induced changes in oxidative stress markers in renal tissues of rats. (<b>A</b>) Malondialdehyde; (<b>B</b>) Glutathione. SAMC was administered intraperitoneally at three different doses, i.e., 10 mg/kg, 20 mg/kg and 30 mg/kg for 20 consecutive days and a single dose of cisplatin (7 mg/kg, i.p) was administered on the 15th day. Values are expressed as mean ± SEM (<span class="html-italic">n</span> = 6). * <span class="html-italic">p</span> &lt; 0.05 vs. control, ** <span class="html-italic">p</span> &lt; 0.01 vs. control, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. cisplatin.</p>
Full article ">Figure 8
<p>Effect of SAMC on cisplatin-induced changes on the expression of proteins in renal tissues of rats. SAMC was administered intraperitoneally at three different doses, i.e., 10 mg/kg, 20 mg/kg and 30 mg/kg for 20 consecutive days and a single dose of cisplatin (7 mg/kg, i.p) was administered on the 15th day. The expression levels of transforming growth factor-β (TGFβ1), cyclooxygenase-2 (COX-2), Nrf2 and NQO1 were analyzed by Western blot. Equal protein loading was confirmed by analysis of GAPDH (glyceraldehyde 3-phosphate dehydrogenase) in the protein extracts.</p>
Full article ">Figure 9
<p>Effect of SAMC on the levels of renal inflammatory cytokines in cisplatin-induced nephrotoxicity. SAMC was administered intraperitoneally at three different doses, i.e., 10 mg/kg, 20 mg/kg and 30 mg/kg for 20 consecutive days and a single dose of cisplatin (7 mg/kg, i.p) was administered on the 15th day. On 20th day, serum levels of tumor necrosis factor (TNF)-α (<b>A</b>) and interleukin (IL)-1β (<b>B</b>) were recorded. Values are expressed as mean ± SEM (<span class="html-italic">n</span> = 6). ** <span class="html-italic">p</span> &lt; 0.01 vs. control, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. cisplatin.</p>
Full article ">Figure 10
<p>Effect of SAMC on nuclear factor NF-κB expression in cisplatin-induced renal injury in rats. Bars indicate 50 μm.</p>
Full article ">
2723 KiB  
Article
Catechol Groups Enable Reactive Oxygen Species Scavenging-Mediated Suppression of PKD-NFkappaB-IL-8 Signaling Pathway by Chlorogenic and Caffeic Acids in Human Intestinal Cells
by Hee Soon Shin, Hideo Satsu, Min-Jung Bae, Mamoru Totsuka and Makoto Shimizu
Nutrients 2017, 9(2), 165; https://doi.org/10.3390/nu9020165 - 20 Feb 2017
Cited by 58 | Viewed by 8946
Abstract
Chlorogenic acid (CHA) and caffeic acid (CA) are phenolic compounds found in coffee, which inhibit oxidative stress-induced interleukin (IL)-8 production in intestinal epithelial cells, thereby suppressing serious cellular injury and inflammatory intestinal diseases. Therefore, we investigated the anti-inflammatory mechanism of CHA and CA, [...] Read more.
Chlorogenic acid (CHA) and caffeic acid (CA) are phenolic compounds found in coffee, which inhibit oxidative stress-induced interleukin (IL)-8 production in intestinal epithelial cells, thereby suppressing serious cellular injury and inflammatory intestinal diseases. Therefore, we investigated the anti-inflammatory mechanism of CHA and CA, both of which inhibited hydrogen peroxide (H2O2)-induced IL-8 transcriptional activity. They also significantly suppressed nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcriptional activity, nuclear translocation of the p65 subunit, and phosphorylation of IκB kinase (IKK). Additionally, upstream of IKK, protein kinase D (PKD) was also suppressed. Finally, we found that they scavenged H2O2-induced reactive oxygen species (ROS) and the functional moiety responsible for the anti-inflammatory effects of CHA and CA was the catechol group. Therefore, we conclude that the presence of catechol groups in CHA and CA allows scavenging of intracellular ROS, thereby inhibiting H2O2-induced IL-8 production via suppression of PKD-NF-κB signaling in human intestinal epithelial cells. Full article
(This article belongs to the Special Issue Nutrition and Diet in IBD)
Show Figures

Figure 1

Figure 1
<p>Chemical structures of analogues derived from chlorogenic acid (CHA) and caffeic acid (CA). Chemical structure of CHA (<b>A</b>); CA (<b>B</b>); cinnamic acid (<b>C</b>); <span class="html-italic">p</span>-coumaric acid (<b>D</b>); <span class="html-italic">m</span>-coumaric acid (<b>E</b>); protocatechuic acid (<b>F</b>); and dihydrocaffeic acid (<b>G</b>).</p>
Full article ">Figure 2
<p>Inhibitory effect of chlorogenic acid (CHA) and caffeic acid (CA) on hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced interleukin (IL)-8 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-dependent transcriptional activities in Caco-2 cells. (<b>A</b>,<b>B</b>) Undifferentiated Caco-2 cells were co-transfected with the pGL-3 basic vector containing <span class="html-italic">IL-8</span> promoter region (<span class="html-italic">C/EBP</span>, <span class="html-italic">AP-1</span>, and <span class="html-italic">NF-κB</span>) and <span class="html-italic">pRL-CMV</span> control vector; (<b>C</b>,<b>D</b>) Undifferentiated Caco-2 cells were co-transfected with the pGL-3 promoter vector containing four binding sites (5′-TGGAATTTCCTCT-3′) of <span class="html-italic">NF-κB</span> and <span class="html-italic">pRL-CMV</span> control vector; (<b>A</b>,<b>C</b>) Cells were also treated with 1 mM H<sub>2</sub>O<sub>2</sub> and 0.5–1 mM CHA; and (<b>B</b>,<b>D</b>) 0.25–0.5-mM CA for 24 h. <span class="html-italic">IL-8</span> and <span class="html-italic">NF-κB</span> transcriptional activities were estimated using a luciferase assay. Values are mean ± SE (<span class="html-italic">n</span> = 3). Means that have no letter in common are significantly different from each other (<span class="html-italic">p</span> &lt; 0.05) by Tukey’s test.</p>
Full article ">Figure 3
<p>Chlorogenic acid (CHA) and caffeic acid (CA) suppressed activation of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced protein kinase D (PKD)-I-κB kinase (IKK)-nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling. Caco-2 cells were pre-incubated for 3 h with 0.25–2 mM CHA or CA, and then exposed to 2 mM H<sub>2</sub>O<sub>2</sub> for 1 h (p65), 10 min (IKK), or 5 min (PKD). (<b>A</b>) CHA and (<b>C</b>) CA were also added to Caco-2 cells at a concentration equal to that used for pretreatment. For quantification of p65, whole proteins extracted from Caco-2 cells were separated into cytosol and nuclear fractions. In addition, whole proteins extracted from Caco-2 cells were investigated for activation of IKK or PKD by comparing regular and phospho-IKK or phospho-PKD using Western blotting with GAPDH as a housekeeping protein. Data represent three independent experiments, and densitographic analysis of these bands was performed (<b>B</b>,<b>D</b>). Values are mean ± SE (<span class="html-italic">n</span> = 3). Means that have no letter in common are significantly different from each other (<span class="html-italic">p</span> &lt; 0.05) by Tukey’s test.</p>
Full article ">Figure 4
<p>Reactive oxygen species (ROS) scavenging capacity of chlorogenic acid (CHA) and caffeic acid (CA). Caco-2 cells were pre-incubated for 3 h with 1 mM CHA or CA and then 10 μM H<sub>2</sub>DCFDA was added for 5 min after washing twice with HBSS. Caco-2 cells were exposed to 2 mM hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) for 1 h after washing twice with HBSS. (<b>A</b>) H<sub>2</sub>DCFDA fluorescence was measured using a plate reader with an excitation and emission wavelengths of 485 and 544 nm, respectively; (<b>B</b>) Caco-2 cells cultured on an eight-chambered cover glass were treated under similar conditions, and fluorescence was observed by fluorescence microscopy. Three ROS were observed in cells including (<b>C</b>) superoxide; (<b>D</b>) H<sub>2</sub>O<sub>2</sub>; and (<b>E</b>) hydroxyl radical. Superoxide produced by xanthine oxidase was detected using a luminometer. H<sub>2</sub>O<sub>2</sub> and hydroxyl radicals induced by Fenton reaction were measured using a microplate reader and luminometer. Catechol, catalase, and vitamin C were used as positive controls, and flavone was a negative control. Values are mean ± SE (<span class="html-italic">n</span> = 3). Means that have no letter in common are significantly different from each other (<span class="html-italic">p</span> &lt; 0.05) by Tukey’s test.</p>
Full article ">Figure 5
<p>Effects of chlorogenic acid (CHA) and caffeic acid (CA) derivatives ((<b>A</b>–<b>G</b>), as shown in <a href="#nutrients-09-00165-f001" class="html-fig">Figure 1</a>) on hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced interleukin (IL)-8 production. (<b>A</b>) Caco-2 cells were exposed to 2 mM H<sub>2</sub>O<sub>2</sub> and treated with 1 mM of each compound. After 24 h, culture medium was collected and IL-8 secretion was determined using enzyme-linked immunosorbent assay (ELISA); (<b>B</b>) IL-8 mRNA expression was measured 3 h after treatment using real-time reverse transcription polymerase chain reaction (qRT-PCR). Values are mean ± SE (<span class="html-italic">n</span> = 3). Means that have no letter in common are significantly different from each other (<span class="html-italic">p</span> &lt; 0.05) by Tukey’s test.</p>
Full article ">Figure 6
<p>Proposed anti-inflammatory mechanism of chlorogenic acid (CHA) and caffeic acid (CA) in human intestinal epithelial cells.</p>
Full article ">
948 KiB  
Article
Individual Diet Modeling Shows How to Balance the Diet of French Adults with or without Excessive Free Sugar Intakes
by Anne Lluch, Matthieu Maillot, Rozenn Gazan, Florent Vieux, Fabien Delaere, Sarah Vaudaine and Nicole Darmon
Nutrients 2017, 9(2), 162; https://doi.org/10.3390/nu9020162 - 20 Feb 2017
Cited by 27 | Viewed by 8567
Abstract
Dietary changes needed to achieve nutritional adequacy for 33 nutrients were determined for 1719 adults from a representative French national dietary survey. For each individual, an iso-energy nutritionally adequate diet was generated using diet modeling, staying as close as possible to the observed [...] Read more.
Dietary changes needed to achieve nutritional adequacy for 33 nutrients were determined for 1719 adults from a representative French national dietary survey. For each individual, an iso-energy nutritionally adequate diet was generated using diet modeling, staying as close as possible to the observed diet. The French food composition table was completed with free sugar (FS) content. Results were analyzed separately for individuals with FS intakes in their observed diets ≤10% or >10% of their energy intake (named below FS-ACCEPTABLE and FS-EXCESS, respectively). The FS-EXCESS group represented 41% of the total population (average energy intake of 14.2% from FS). Compared with FS-ACCEPTABLE individuals, FS-EXCESS individuals had diets of lower nutritional quality and consumed more energy (2192 vs. 2123 kcal/day), particularly during snacking occasions (258 vs. 131 kcal/day) (all p-values < 0.01). In order to meet nutritional targets, for both FS-ACCEPTABLE and FS-EXCESS individuals, the main dietary changes in optimized diets were significant increases in fresh fruits, starchy foods, water, hot beverages and plain yogurts; and significant decreases in mixed dishes/sandwiches, meat/eggs/fish and cheese. For FS-EXCESS individuals only, the optimization process significantly increased vegetables and significantly decreased sugar-sweetened beverages, sweet products and fruit juices. The diets of French adults with excessive intakes of FS are of lower nutritional quality, but can be optimized via specific dietary changes. Full article
Show Figures

Figure 1

Figure 1
<p>Weight changes <sup>1</sup> between observed and optimized diets (g/day) in food categories (<b>A</b>); and in food sub-categories for: fruits/vegetables/nuts (<b>B</b>); starchy foods (<b>C</b>); dairy products (<b>D</b>); sweet products (<b>E</b>); and beverages including water (<b>F</b>), in FS-ACCEPTABLE and FS-EXCESS individuals <sup>2</sup>. <sup>1</sup> Italic and bold values indicate a weight change significantly different from zero adjusted for age, gender, energy intake, smoker status, BMI, socio-professional status, composition of the family and sitting time; <sup>2</sup> the * symbol means that the weight changes were significantly different between FS-ACCEPTABLE and FS-EXCESS groups, adjusted for age, gender, energy intake, smoker status, BMI, socio-professional status, composition of the family and sitting time.</p>
Full article ">Figure 2
<p>Amount of sugars (total, free, non-free) <sup>1</sup> in observed and optimized diets (g/d), from main food category contributors in: FS-ACCEPTABLE (<b>a</b>); and FS-EXCESS (<b>b</b>) individuals <sup>2</sup>. <sup>1</sup> Amounts of sugars lower than 4 g not labeled; <sup>2</sup> For both FS-ACCEPTABLE and FS-EXCESS, total sugars, free sugars and non-free sugars were significantly different between observed and optimized diets after adjustment for age, gender, energy intake, smoker status, BMI, socio-professional status, composition of the family and sitting time.</p>
Full article ">
538 KiB  
Review
Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review
by Marilia Carabotti, Bruno Annibale, Carola Severi and Edith Lahner
Nutrients 2017, 9(2), 161; https://doi.org/10.3390/nu9020161 - 20 Feb 2017
Cited by 54 | Viewed by 20473
Abstract
Symptomatic uncomplicated diverticular disease (SUDD) is a syndrome characterized by recurrent abdominal symptoms in patients with colonic diverticula. There is some evidence that a high-fiber diet or supplemental fibers may reduce symptoms in SUDD patients and a high-fiber diet is commonly suggested for [...] Read more.
Symptomatic uncomplicated diverticular disease (SUDD) is a syndrome characterized by recurrent abdominal symptoms in patients with colonic diverticula. There is some evidence that a high-fiber diet or supplemental fibers may reduce symptoms in SUDD patients and a high-fiber diet is commonly suggested for these patients. This systematic review aims to update the evidence on the efficacy of fiber treatment in SUDD, in terms of a reduction in symptoms and the prevention of acute diverticulitis. According to PRISMA, we identified studies on SUDD patients treated with fibers (PubMed and Scopus). The quality of these studies was evaluated by the Jadad scale. The main outcome measures were a reduction of abdominal symptoms and the prevention of acute diverticulitis. Nineteen studies were included, nine with dietary fiber and 10 with supplemental fiber, with a high heterogeneity concerning the quantity and quality of fibers employed. Single studies suggest that fibers, both dietary and supplemental, could be beneficial in SUDD, even if the quality is very low, with just one study yielding an optimal score. The presence of substantial methodological limitations, the heterogeneity of the therapeutic regimens employed, and the lack of ad hoc designed studies, did not permit a summary of the outcome measure. Thus, the benefit of dietary or supplemental fiber in SUDD patients still needs to be established. Full article
(This article belongs to the Special Issue Dietary Fibers and Human Health)
Show Figures

Figure 1

Figure 1
<p>Flow-chart of study selection.</p>
Full article ">
10677 KiB  
Article
Certain Grain Foods Can Be Meaningful Contributors to Nutrient Density in the Diets of U.S. Children and Adolescents: Data from the National Health and Nutrition Examination Survey, 2009–2012
by Yanni Papanikolaou and Victor L. Fulgoni
Nutrients 2017, 9(2), 160; https://doi.org/10.3390/nu9020160 - 20 Feb 2017
Cited by 27 | Viewed by 10022
Abstract
Grain foods may play an important role in delivering nutrients to the diet of children and adolescents. The present study determined grain food sources of energy/nutrients in U.S. children and adolescents using data from the National Health and Nutrition Examination Survey, 2009–2012. Analyses [...] Read more.
Grain foods may play an important role in delivering nutrients to the diet of children and adolescents. The present study determined grain food sources of energy/nutrients in U.S. children and adolescents using data from the National Health and Nutrition Examination Survey, 2009–2012. Analyses of grain food sources were conducted using a 24-h recall in participants 2–18 years old (N = 6109). Sources of nutrients contained in grain foods were determined using U.S. Department of Agriculture nutrient composition databases and excluded mixed dishes. Mean energy and nutrient intakes from the total diet and from various grain foods were adjusted for the sample design using appropriate weights. All grains provided 14% ± 0.2% kcal/day (263 ± 5 kcal/day), 22.5% ± 0.3% (3 ± 0.1 g/day) dietary fiber, 39.3% ± 0.5% (238 ± 7 dietary folate equivalents (DFE)/day) folate and 34.9% ± 0.5% (5.6 ± 0.1 mg/day) iron in the total diet in children and adolescents. The current analyses showed that certain grain foods, in particular breads, rolls and tortillas, ready-to-eat cereals and quick breads and bread products, are meaningful contributors of folate, iron, thiamin, niacin and dietary fiber, a nutrient of public health concern as outlined by the 2015–2020 Dietary Guidelines for Americans. Thus, specific grain foods contribute to nutrient density and have the potential to increase the consumption of several under-consumed nutrients in children and adolescents. Full article
Show Figures

Figure 1

Figure 1
<p>Grain foods sources of energy and nutrients for children and adolescents, 2–18 years old (<span class="html-italic">N</span> = 6109, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 2
<p>Grain foods sources of energy and nutrients for children 1–3 years old (<span class="html-italic">N</span> = 1423, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 3
<p>Grain foods sources of energy and nutrients for children 4–8 years old (<span class="html-italic">N</span> = 1917, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 4
<p>Grain foods sources of energy and nutrients for children and adolescents 9–13 years old (<span class="html-italic">N</span> = 1730, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 5
<p>Grain foods sources of energy and nutrients for adolescents 14–18 years old (<span class="html-italic">N</span> = 1508, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 6
<p>Breads, Rolls and tortilla as sources of energy and nutrients for children and adolescents 2–18 years old (<span class="html-italic">N</span> = 6109, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 7
<p>Breads, rolls and tortilla as sources of energy and nutrients for children 1–3 years old (<span class="html-italic">N</span> = 1423, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 8
<p>Breads, rolls and tortilla as sources of energy and nutrients for children 4–8 years old (<span class="html-italic">N</span> = 1917, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 9
<p>Breads, rolls and tortilla as sources of energy and nutrients for children and adolescents 9–13 years old (<span class="html-italic">N</span> = 1730, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density</p>
Full article ">Figure 10
<p>Breads, rolls and tortilla as sources of energy and nutrients for adolescents 14–18 years old (<span class="html-italic">N</span> = 1508, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 11
<p>Ready-to-eat cereals as sources of energy and nutrients for children and adolescents (<span class="html-italic">N</span> = 6109, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 12
<p>Ready-to-eat cereals as sources of energy and nutrients for children 1–3 years old (<span class="html-italic">N</span> = 1423, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 13
<p>Ready-to-eat cereals as sources of energy and nutrients for children 4–8 years old (<span class="html-italic">N</span> = 1917, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 14
<p>Ready-to-eat cereals as sources of energy and nutrients for children and adolescents 9–13 years old (<span class="html-italic">N</span> = 1730, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 15
<p>Ready-to-eat cereals as sources of energy and nutrients for adolescents 14–18 years old (<span class="html-italic">N</span> = 1508, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 16
<p>Cooked grains as sources of energy and nutrients for children and adolescents 2–18 years old (<span class="html-italic">N</span> = 6109, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 17
<p>Cooked grains as sources of energy and nutrients for children 1–3 years old (<span class="html-italic">N</span> = 1423, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 18
<p>Cooked grains as sources of energy and nutrients for children 4–8 years old (<span class="html-italic">N</span> = 1917, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 19
<p>Cooked grains as sources of energy and nutrients for children and adolescents 9–13 years old (<span class="html-italic">N</span> = 1730, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 20
<p>Cooked grains as sources of energy and nutrients for adolescents 14–18 years old (<span class="html-italic">N</span> = 1508, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 21
<p>Quick breads and bread products as sources of energy and nutrients for children and adolescents 2–18 years old (<span class="html-italic">N</span> = 6109, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 22
<p>Quick breads and bread products as sources of energy and nutrients for children 1–3 years old (<span class="html-italic">N</span> = 1423, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 23
<p>Quick breads and bread products as sources of energy and nutrients for children 4–8 years old (<span class="html-italic">N</span> = 1917, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 24
<p>Quick breads and bread products as sources of energy and nutrients for children and adolescents 9–13 years old (<span class="html-italic">N</span> = 1730, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 25
<p>Quick breads and bread products as sources of energy and nutrients for adolescents 14–18 years old (<span class="html-italic">N</span> = 1508, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 26
<p>Sweet bakery products as sources of energy and nutrients for children and adolescents 2–18 years old (<span class="html-italic">N</span> = 6109, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 27
<p>Sweet bakery products as sources of energy and nutrients for children 1–3 years old (<span class="html-italic">N</span> = 1423, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 28
<p>Sweet bakery products as sources of energy and nutrients for children 4–8 years old (<span class="html-italic">N</span> = 1917, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 29
<p>Sweet bakery products as sources of energy and nutrients for children and adolescents 9–13 years old (<span class="html-italic">N</span> = 1730, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">Figure 30
<p>Sweet bakery products as sources of energy and nutrients for adolescents 14–18 years old (<span class="html-italic">N</span> = 1508, daily intake data): DFE = Dietary Folate Equivalents; solid red line represents percentage of energy (kcal) provided in the diet relative to nutrients—nutrients above the red line show the grain food’s contribution to nutrient density.</p>
Full article ">
2152 KiB  
Review
Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis
by Ana Cañete, Elena Cano, Ramón Muñoz-Chápuli and Rita Carmona
Nutrients 2017, 9(2), 159; https://doi.org/10.3390/nu9020159 - 20 Feb 2017
Cited by 92 | Viewed by 14381
Abstract
Vitamin A is an essential micronutrient throughout life. Its physiologically active metabolite retinoic acid (RA), acting through nuclear retinoic acid receptors (RARs), is a potent regulator of patterning during embryonic development, as well as being necessary for adult tissue homeostasis. Vitamin A deficiency [...] Read more.
Vitamin A is an essential micronutrient throughout life. Its physiologically active metabolite retinoic acid (RA), acting through nuclear retinoic acid receptors (RARs), is a potent regulator of patterning during embryonic development, as well as being necessary for adult tissue homeostasis. Vitamin A deficiency during pregnancy increases risk of maternal night blindness and anemia and may be a cause of congenital malformations. Childhood Vitamin A deficiency can cause xerophthalmia, lower resistance to infection and increased risk of mortality. RA signaling appears to be essential for expression of genes involved in developmental hematopoiesis, regulating the endothelial/blood cells balance in the yolk sac, promoting the hemogenic program in the aorta-gonad-mesonephros area and stimulating eryrthropoiesis in fetal liver by activating the expression of erythropoietin. In adults, RA signaling regulates differentiation of granulocytes and enhances erythropoiesis. Vitamin A may facilitate iron absorption and metabolism to prevent anemia and plays a key role in mucosal immune responses, modulating the function of regulatory T cells. Furthermore, defective RA/RARα signaling is involved in the pathogenesis of acute promyelocytic leukemia due to a failure in differentiation of promyelocytes. This review focuses on the different roles played by vitamin A/RA signaling in physiological and pathological mouse hematopoiesis duddurring both, embryonic and adult life, and the consequences of vitamin A deficiency for the blood system. Full article
(This article belongs to the Special Issue Vitamin A Update 2016)
Show Figures

Figure 1

Figure 1
<p>Role of vitamin A/retinol in adult hematopoiesis. This picture shows the main molecular pathways leading from the vitamin A sources to the target genes of the retinoic acid (RA, the active form of vitamin A) related with hematopoiesis in the tissues. Retinol or provitamin A is ingested and absorbed through the intestine, transported by retinol-binding proteins and stored in the liver. Retinol is transformed by the cells into RA by alcohol and aldehyde dehydrogenases (ADHs and RALDHs respectively). RA is transported by cellular retinoic acid binding proteins (CRABP) and it can be degraded by CYP26 or translocated to the nucleus, where it binds and activates nuclear retinoid acid receptors (RARs and RXRs), displacing co-repressors and recruiting coactivators of the transcription of target genes. In this way, RA regulates the developmental hematopoiesis, modulates lympho and granulopoiesis and contributes to the homeostasis of the hematopoietic stem cells. Vitamin D receptor (VDR) can also dimerize with RXRs and modulate the immune response.</p>
Full article ">Figure 2
<p>Hematopoietic sites in the embryo (<b>left</b>) and adult mouse (<b>right</b>). The main functions played by vitamin A/RA signaling are described between parentheses. Black arrows represent the main routes of migration of progenitors between the hematopoietic organs and tissues. Exchange of progenitors between embryonic organs is also possible. It is unknown if RA signaling plays an intrinsic role on placental hematopoietic stem cells (HSC). AGM: Aorta-Gonad-Mesonephros.</p>
Full article ">Figure 3
<p>Vitamin A in developmental hematopoiesis. The picture shows immunolocalization of the enzyme RALDH2, catalyzing a key step in the generation of retinoic acid from retinol in the aorta-gonad-mesonephros. RALDH2 is expressed in the coelomic epithelium of the intermediate mesoderm (IM) (arrows in A) by the stage E9.5 (<b>A</b>) and later (<b>B</b>) in mesenchymal cells of area, where the definitive population of hematopoietic stem cells is generated, between the aorta (AO), the cardinal veins (CV) and the gonadal/mesonephric mesoderm (G-M). This embryonic RA signaling is essential for the emergence of the definitive blood progenitors, as described in the text. M: mesentery; NT: neural tube.</p>
Full article ">
729 KiB  
Article
Effects of Acute Blueberry Flavonoids on Mood in Children and Young Adults
by Sundus Khalid, Katie L. Barfoot, Gabrielle May, Daniel J. Lamport, Shirley A. Reynolds and Claire M. Williams
Nutrients 2017, 9(2), 158; https://doi.org/10.3390/nu9020158 - 20 Feb 2017
Cited by 62 | Viewed by 36513
Abstract
Epidemiological evidence suggests that consumption of flavonoids (usually via fruits and vegetables) is associated with decreased risk of developing depression. One plausible explanation for this association is the well-documented beneficial effects of flavonoids on executive function (EF). Impaired EF is linked to cognitive [...] Read more.
Epidemiological evidence suggests that consumption of flavonoids (usually via fruits and vegetables) is associated with decreased risk of developing depression. One plausible explanation for this association is the well-documented beneficial effects of flavonoids on executive function (EF). Impaired EF is linked to cognitive processes (e.g., rumination) that maintain depression and low mood; therefore, improved EF may reduce depressionogenic cognitive processes and improve mood. Study 1: 21 young adults (18–21 years old) consumed a flavonoid-rich blueberry drink and a matched placebo in a counterbalanced cross-over design. Study 2: 50 children (7–10 years old) were randomly assigned to a flavonoid-rich blueberry drink or a matched placebo. In both studies, participants and researchers were blind to the experimental condition, and mood was assessed using the Positive and Negative Affect Schedule before and 2 h after consumption of the drinks. In both studies, the blueberry intervention increased positive affect (significant drink by session interaction) but had no effect on negative affect. This observed effect of flavonoids on positive affect in two independent samples is of potential practical value in improving public health. If the effect of flavonoids on positive affect is replicated, further investigation will be needed to identify the mechanisms that link flavonoid interventions with improved positive mood. Full article
Show Figures

Figure 1

Figure 1
<p>Mean PANAS-NOW Mood scores in adults aged 18–21 years: (<b>a</b>) Mean PA scores pre- and post-consumption of placebo and WBB drinks; (<b>b</b>) Mean NA scores pre- and post-consumption of placebo and WBB drinks.</p>
Full article ">Figure 2
<p>Mean PANAS-C scores in children aged 7–10 years: (<b>a</b>) Mean PA scores pre- and post-consumption of placebo and WBB drinks; (<b>b</b>) Mean NA scores pre- and post-consumption of placebo and WBB drinks. * Significant at &lt;0.05. Attained from post-hoc paired samples <span class="html-italic">t</span>-test.</p>
Full article ">
2544 KiB  
Review
Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials
by Hajar Mazahery, Welma Stonehouse, Maryam Delshad, Marlena C. Kruger, Cathryn A. Conlon, Kathryn L. Beck and Pamela R. Von Hurst
Nutrients 2017, 9(2), 155; https://doi.org/10.3390/nu9020155 - 19 Feb 2017
Cited by 97 | Viewed by 14124
Abstract
Omega-3 long chain polyunsaturated fatty acid supplementation (n-3 LCPUFA) for treatment of Autism Spectrum Disorder (ASD) is popular. The results of previous systematic reviews and meta-analyses of n-3 LCPUFA supplementation on ASD outcomes were inconclusive. Two meta-analyses were conducted; meta-analysis [...] Read more.
Omega-3 long chain polyunsaturated fatty acid supplementation (n-3 LCPUFA) for treatment of Autism Spectrum Disorder (ASD) is popular. The results of previous systematic reviews and meta-analyses of n-3 LCPUFA supplementation on ASD outcomes were inconclusive. Two meta-analyses were conducted; meta-analysis 1 compared blood levels of LCPUFA and their ratios arachidonic acid (ARA) to docosahexaenoic acid (DHA), ARA to eicosapentaenoic acid (EPA), or total n-6 to total n-3 LCPUFA in ASD to those of typically developing individuals (with no neurodevelopmental disorders), and meta-analysis 2 compared the effects of n-3 LCPUFA supplementation to placebo on symptoms of ASD. Case-control studies and randomised controlled trials (RCTs) were identified searching electronic databases up to May, 2016. Mean differences were pooled and analysed using inverse variance models. Heterogeneity was assessed using I2 statistic. Fifteen case-control studies (n = 1193) were reviewed. Compared with typically developed, ASD populations had lower DHA (−2.14 [95% CI −3.22 to −1.07]; p < 0.0001; I2 = 97%), EPA (−0.72 [95% CI −1.25 to −0.18]; p = 0.008; I2 = 88%), and ARA (−0.83 [95% CI, −1.48 to −0.17]; p = 0.01; I2 = 96%) and higher total n-6 LCPUFA to n-3 LCPUFA ratio (0.42 [95% CI 0.06 to 0.78]; p = 0.02; I2 = 74%). Four RCTs were included in meta-analysis 2 (n = 107). Compared with placebo, n-3 LCPUFA improved social interaction (−1.96 [95% CI −3.5 to −0.34]; p = 0.02; I2 = 0) and repetitive and restricted interests and behaviours (−1.08 [95% CI −2.17 to −0.01]; p = 0.05; I2 = 0). Populations with ASD have lower n-3 LCPUFA status and n-3 LCPUFA supplementation can potentially improve some ASD symptoms. Further research with large sample size and adequate study duration is warranted to confirm the efficacy of n-3 LCPUFA. Full article
(This article belongs to the Special Issue Dietary Intake and Behavior in Children)
Show Figures

Figure 1

Figure 1
<p>Flow diagram for selection of studies (PRISMA flow diagram).</p>
Full article ">Figure 2
<p>Forest plots of mean (95% confidence interval (CI)) weighted difference in blood levels of docosahexaenoic acid (DHA) (<b>A</b>); eicosapentaenoic acid (EPA) (<b>B</b>); and arachidonic acid (ARA) (<b>C</b>) between populations with Autism Spectrum Disorder (ASD) and typically developing controls stratified for subgroups with studies including all age groups (children, teenagers, and adults) vs. those including children only. Direction of effect (negative, lower mean in ASD group; positive, lower mean in control group; zero, no difference between groups).</p>
Full article ">Figure 2 Cont.
<p>Forest plots of mean (95% confidence interval (CI)) weighted difference in blood levels of docosahexaenoic acid (DHA) (<b>A</b>); eicosapentaenoic acid (EPA) (<b>B</b>); and arachidonic acid (ARA) (<b>C</b>) between populations with Autism Spectrum Disorder (ASD) and typically developing controls stratified for subgroups with studies including all age groups (children, teenagers, and adults) vs. those including children only. Direction of effect (negative, lower mean in ASD group; positive, lower mean in control group; zero, no difference between groups).</p>
Full article ">Figure 3
<p>Forest plots of mean (95% confidence interval (CI)) weighted difference in the ratio of arachidonic acid (ARA) to docosahexaenoic acid (DHA) (<b>A</b>) and the ratio of ARA to eicosapentaenoic acid (EPA) (<b>B</b>) between populations with Autism Spectrum Disorder (ASD) and typically developing children stratified for subgroups with studies including all age groups (children, teenagers, and adults) vs. young children only. Direction of effect (negative, lower mean in ASD group; positive, lower mean in control group; zero, no difference between groups).</p>
Full article ">Figure 4
<p>Forest plots of mean (95% confidence interval (CI)) weighted difference in the total <span class="html-italic">n</span>-3 long chain polyunsaturated fatty acids (<span class="html-italic">n</span>-3 LCPUFA) (<b>A</b>) and total <span class="html-italic">n</span>-6 long chain polyunsaturated fatty acids (<span class="html-italic">n</span>-6 LCPUFA) (<b>B</b>) between populations with Autism Spectrum Disorder (ASD) and typically developing children stratified for subgroups with studies including all age groups (children, teenagers, and adults) vs. young children only. Direction of effect (negative, lower mean in ASD group; positive, lower mean in control group; zero, no difference between groups).</p>
Full article ">Figure 5
<p>Forest plot of mean (95% confidence interval (CI)) weighted difference in the ratio of total <span class="html-italic">n</span>-6 long chain polyunsaturated fatty acids (<span class="html-italic">n</span>-6 LCPUFA) to total <span class="html-italic">n</span>-3 long chain polyunsaturated fatty acids (<span class="html-italic">n</span>-3 LCPUFA) between populations with Autism Spectrum Disorder (ASD) and typically developing children stratified for subgroups with studies including all age groups (children, teenagers, and adults) vs. young children only. Direction of effect (negative, lower mean in ASD group; positive, lower mean in control group; zero, no difference between groups).</p>
Full article ">Figure 6
<p>Forest plot of mean (95% confidence interval (CI)) fixed difference in change in social interaction (ABC) (<b>A</b>); communication (ABC) (<b>B</b>); and repetitive and restricted interests and behaviours (ABC) (<b>C</b>) in populations with Autism Spectrum Disorder (ASD) receiving <span class="html-italic">n</span>-3 long chain polyunsaturated fatty acid supplementation (LCPUFA) and placebo. Direction of effect (negative, more improvement in <span class="html-italic">n</span>-3 LCPUFA groups; positive, more improvement in placebo group; zero, no difference between groups).</p>
Full article ">Figure 6 Cont.
<p>Forest plot of mean (95% confidence interval (CI)) fixed difference in change in social interaction (ABC) (<b>A</b>); communication (ABC) (<b>B</b>); and repetitive and restricted interests and behaviours (ABC) (<b>C</b>) in populations with Autism Spectrum Disorder (ASD) receiving <span class="html-italic">n</span>-3 long chain polyunsaturated fatty acid supplementation (LCPUFA) and placebo. Direction of effect (negative, more improvement in <span class="html-italic">n</span>-3 LCPUFA groups; positive, more improvement in placebo group; zero, no difference between groups).</p>
Full article ">Figure 7
<p>Forest plot of mean (95% confidence interval (CI)) fixed difference in change in hyperactivity (ABC) (<b>A</b>) and irritability (ABC) (<b>B</b>) in populations with Autism Spectrum Disorder (ASD) receiving <span class="html-italic">n</span>-3 long chain polyunsaturated fatty acid supplementation (<span class="html-italic">n</span>-3 LCPUFA) and placebo. Direction of effect (negative, more improvement in <span class="html-italic">n</span>-3 LCPUFA group; positive, more improvement in placebo group; zero, no difference between groups).</p>
Full article ">
628 KiB  
Article
The Cross-Sectional Association between Consumption of the Recommended Five Food Group “Grain (Cereal)”, Dietary Fibre and Anthropometric Measures among Australian Adults
by Flavia Fayet-Moore, Peter Petocz, Andrew McConnell, Kate Tuck and Marie Mansour
Nutrients 2017, 9(2), 157; https://doi.org/10.3390/nu9020157 - 18 Feb 2017
Cited by 9 | Viewed by 6409
Abstract
The Australian Dietary Guidelines recommended “grain (cereal)” core food group includes both refined and whole grain foods, but excludes those that are discretionary (i.e., cakes). We investigated the association between daily serves from the “grain (cereal)” group and its effect on fibre and [...] Read more.
The Australian Dietary Guidelines recommended “grain (cereal)” core food group includes both refined and whole grain foods, but excludes those that are discretionary (i.e., cakes). We investigated the association between daily serves from the “grain (cereal)” group and its effect on fibre and adiposity. Data from Australian adults in the 2011–2012 National Nutrition and Physical Activity Survey were used (n = 9341). Participants were categorised by serves of core grain foods and general linear models were used to investigate the effect of demographic, socioeconomic, and dietary covariates on waist circumference, body mass index (BMI) and fibre intake. Compared to core grain avoiders (0 serves), high consumers (6+ serves/day) were: more likely male and socially advantaged, had a healthier dietary pattern, less likely dieting, overweight or obese, and were at lower risk of metabolic complications. After adjustment for age, sex and energy intake, there was an inverse relationship between core grain serves intake and BMI (p < 0.001), waist circumference (p = 0.001) and a positive relationship with fibre (p < 0.001). Model adjustments for diet and lifestyle factors resulted in a smaller difference in waist circumference (p = 0.006) and BMI (p = 0.006). Core grain serves was significantly associated with higher fibre, but marginally clinically significant for lower adiposity. Full article
Show Figures

Figure 1

Figure 1
<p>Estimated marginal means from models for waist circumference, BMI and fibre by age groups and sex (Model 3). Covariates in the models evaluated at energy intake (MJ) = 8.8, usual fruit intake serves = 1.62, usual vegetable intake serves = 2.36, percent of energy that is discretionary (%) = 32.7).</p>
Full article ">
306 KiB  
Conference Report
“Cocoa and Chocolate: Science and Gastronomy”—The Second Annual Workshop of the Research Institute on Nutrition and Food Security (INSA): 9 November 2016
by Malen Massot‐Cladera, Francisco Pérez‐Cano, Rafael Llorach and Mireia Urpi‐Sarda
Nutrients 2017, 9(2), 156; https://doi.org/10.3390/nu9020156 - 17 Feb 2017
Cited by 3 | Viewed by 6624
Abstract
The Research Institute on Nutrition and Food Security at the University of Barcelona (INSA‐UB) was founded in 2005 by twenty‐two research groups from the Faculties of Pharmacy and Food Science; Biology; Chemistry; and Geography and History, as well as other UB‐affiliated centers and [...] Read more.
The Research Institute on Nutrition and Food Security at the University of Barcelona (INSA‐UB) was founded in 2005 by twenty‐two research groups from the Faculties of Pharmacy and Food Science; Biology; Chemistry; and Geography and History, as well as other UB‐affiliated centers and hospitals [...] Full article
1033 KiB  
Article
Exploring the Effect of Lactium™ and Zizyphus Complex on Sleep Quality: A Double-Blind, Randomized Placebo-Controlled Trial
by Andrew Scholey, Sarah Benson, Amy Gibbs, Naomi Perry, Jerome Sarris and Greg Murray
Nutrients 2017, 9(2), 154; https://doi.org/10.3390/nu9020154 - 17 Feb 2017
Cited by 23 | Viewed by 12460
Abstract
Acute, non-clinical insomnia is not uncommon. Sufferers commonly turn to short-term use of herbal supplements to alleviate the symptoms. This placebo-controlled, double-blind study investigated the efficacy of LZComplex3 (lactium™, Zizyphus, Humulus lupulus, magnesium and vitamin B6), in otherwise healthy adults with [...] Read more.
Acute, non-clinical insomnia is not uncommon. Sufferers commonly turn to short-term use of herbal supplements to alleviate the symptoms. This placebo-controlled, double-blind study investigated the efficacy of LZComplex3 (lactium™, Zizyphus, Humulus lupulus, magnesium and vitamin B6), in otherwise healthy adults with mild insomnia. After a 7-day single-blind placebo run-in, eligible volunteers (n = 171) were randomized (1:1) to receive daily treatment for 2 weeks with LZComplex3 or placebo. Results revealed that sleep quality measured by change in Pittsburgh Sleep Quality Index (PSQI) score improved in both the LZComplex3 and placebo groups. There were no significant between group differences between baseline and endpoint on the primary outcome. The majority of secondary outcomes, which included daytime functioning and physical fatigue, mood and anxiety, cognitive performance, and stress reactivity, showed similar improvements in the LZComplex3 and placebo groups. A similar proportion of participants reported adverse events (AEs) in both groups, with two of four treatment-related AEs in the LZComplex3 group resulting in permanent discontinuation. It currently cannot be concluded that administration of LZComplex3 for 2 weeks improves sleep quality, however, a marked placebo response (despite placebo run-in) and/or short duration of treatment may have masked a potential beneficial effect on sleep quality. Full article
Show Figures

Figure 1

Figure 1
<p>Study design. <b>R</b>* = randomization; D = study day.</p>
Full article ">Figure 2
<p>Participant flow. AE = adverse event, PSQI = Pittsburgh Sleep Quality Index</p>
Full article ">Figure 3
<p>Least squares mean change in total Pittsburgh Sleep Quality Index (PSQI) between baseline (day 0) and end of the observation period (day 21) by treatment group in: (<b>a</b>) the modified intention-to-treat (mITT) population and (<b>b</b>) the per protocol (PP) population.</p>
Full article ">
415 KiB  
Article
Whole Grains Contribute Only a Small Proportion of Dietary Fiber to the U.S. Diet
by Sibylle Kranz, Kevin W. Dodd, Wen Yen Juan, LuAnn K. Johnson and Lisa Jahns
Nutrients 2017, 9(2), 153; https://doi.org/10.3390/nu9020153 - 17 Feb 2017
Cited by 36 | Viewed by 8418
Abstract
Dietary fiber (DF), found in whole fruits, vegetables, and whole grains (WG), is considered a nutrient of concern in the US diet and increased consumption is recommended. The present study was designed to highlight this critical importance of the difference between WG, high-fiber [...] Read more.
Dietary fiber (DF), found in whole fruits, vegetables, and whole grains (WG), is considered a nutrient of concern in the US diet and increased consumption is recommended. The present study was designed to highlight this critical importance of the difference between WG, high-fiber WG, and sources of fiber that are not from WG. The study is based on the two-day diets reported consumed by the nationally representative sample of Americans participating in What We Eat In America, the dietary component of the National Health and Nutrition Examination Survey from 2003–2010. Foods consumed were classified into tertiles of DF and WG and the contribution of fiber by differing levels of WG content were examined. Foods containing high amounts of WG and DF only contributed about 7% of total fiber intake. Overall, grain-based foods contributed 54.5% of all DF consumed. Approximately 39% of DF came from grain foods that contained no WG, rather these foods contained refined grains, which contain only small amounts of DF but are consumed in large quantities. All WG-containing foods combined contributed a total of 15.3% of DF in the American diet. Thus, public health messaging needs to be changed to specifically encourage consumption of WG foods with high levels of DF to address both recommendations. Full article
(This article belongs to the Special Issue Dietary Fibers and Human Health)
Show Figures

Figure 1

Figure 1
<p>Percent of total dietary fiber intake provided by low, medium, and high fiber foods (defined by g fiber/100 g food) in the diets of Americans ages 2–85 years old.</p>
Full article ">
241 KiB  
Article
Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients
by Rameez Imtiaz, Steven Hawken, Brendan B. McCormick, Simon Leung, Swapnil Hiremath and Deborah L. Zimmerman
Nutrients 2017, 9(2), 152; https://doi.org/10.3390/nu9020152 - 17 Feb 2017
Cited by 8 | Viewed by 6056
Abstract
Hyperphosphatemia has been associated with adverse outcomes in patients with end stage kidney disease (ESKD). The purpose of this study was to determine risk factors for hyperphosphatemia in ESKD patients treated with peritoneal dialysis (PD). This information will be used to develop a [...] Read more.
Hyperphosphatemia has been associated with adverse outcomes in patients with end stage kidney disease (ESKD). The purpose of this study was to determine risk factors for hyperphosphatemia in ESKD patients treated with peritoneal dialysis (PD). This information will be used to develop a patient specific phosphate binder application to facilitate patient self-management of serum phosphate. Adult PD patients documented their food, beverage, and phosphate binder intake for three days using a dietitian developed food journal. Phosphate content of meals was calculated using the ESHA Food Processor SQL Software (ESHA Research, Salem, UT, USA). Clinic biochemistry tests and an adequacy assessment (Baxter Adequest program) were done. Univariate logistic regression was used to determine predictors of serum phosphate >1.78 mmol/L. A multivariable logistic regression model was then fit including those variables that achieved a significance level of p < 0.20 in univariate analyses. Sixty patients (38 men, 22 women) completed the protocol; they were 60 ± 17 years old, 50% had a history of diabetes mellitus (DM) and 33% had hyperphosphatemia (PO4 > 1.78 mmol/L). In univariate analysis, the variables associated with an increased risk of hyperphosphatemia with a p-value < 0.2 were male gender (p = 0.13), younger age (0.07), presence of DM (0.005), higher dose of calcium carbonate (0.08), higher parathyroid serum concentration (0.08), lower phosphate intake (0.03), lower measured glomerular filtration rate (0.15), higher phosphate excretion (0.11), and a higher body mass index (0.15). After multivariable logistic regression analysis, younger age (odds ratio (OR) 0.023 per decade, 95% confidence interval (CI) 0.00065 to 0.455; p = 0.012), presence of diabetes (OR 11.40, 95 CI 2.82 to 61.55; p = 0.0003), and measured GFR (OR 0.052 per mL/min decrease; 95% CI 0.0025 to 0.66) were associated with hyperphosphatemia. Our results support that younger age and diabetes mellitus are significant risk factors for hyperphosphatemia. These findings warrant further investigation to determine the potential mechanisms that predispose younger patients and those with DM to hyperphosphatemia. Full article
(This article belongs to the Special Issue Nutrition and Chronic Kidney Disease)
Previous Issue
Next Issue
Back to TopTop